Processing 00000000.tx.1: Genetic Analysis of HNF4A Polymorphisms in Caucasian-American Type 2 Diabetes Allison M. 

Phrase: "Genetic Analysis of HNF4A Polymorphisms"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   767   C0085801:Analysis, Factor [Quantitative Concept]
   750   C0796451:polymorphism analysis [Diagnostic Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in Caucasian-American Type 2 Diabetes Allison M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Bagwell1,2, Jennifer L. 

Phrase: "Bagwell1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Jennifer L."
Processing 00000000.tx.3: Bento2,3, Josyf C. 

Phrase: "Bento2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Josyf C."
Processing 00000000.tx.4: Mychaleckyj2,4,5, Barry I. 

Phrase: "Mychaleckyj2,"

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "Barry I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.5: Freedman3, Carl D. 

Phrase: "Freedman3,"

Phrase: "Carl D."
Processing 00000000.tx.6: Langefeld5, and Donald W. 

Phrase: "Langefeld5,"

Phrase: "and"

Phrase: "Donald W."
Processing 00000000.tx.7: Bowden1,2,3,4 1 Molecular Genetics Program, Wake Forest University School of Medicine, Winston-Salem, North Carolina 2 Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina 3 Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina 4 Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 5 Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Hepatocyte nuclear factor 4 (HNF4A), the gene for the maturity-onset diabetes of the young type 1 monogenic form of type 2 diabetes, is within the type 2 diabeteslinked region on chromosome 20q12-q13.1 and, consequently, is a positional candidate gene for type 2 diabetes in the general population. 

Phrase: "Bowden1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4 1 Molecular Genetics"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   812   C0017398:Genetics [Biomedical Occupation or Discipline]
   812   C0017399:genetics [Biologic Function]
   812   C1521991:Molecular [Qualitative Concept]
   741 E C0567416:Molecule [Substance]

Phrase: "Program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: ","

Phrase: "Wake Forest University School of Medicine,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0013227:Medicine, NOS [Pharmacologic Substance]
   799   C0025118:Medicine [Biomedical Occupation or Discipline]
   799   C0036375:School [Manufactured Object,Organization]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0086312:Forest [Geographic Area]
   799   C0442696:wake [Physiologic Function]
   799   C0585034:WAKE [Temporal Concept]

Phrase: "Winston-Salem,"

Phrase: "North Carolina 2 Center for Human Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205099:Center [Spatial Concept]

Phrase: "Wake Forest University School of Medicine,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0013227:Medicine, NOS [Pharmacologic Substance]
   799   C0025118:Medicine [Biomedical Occupation or Discipline]
   799   C0036375:School [Manufactured Object,Organization]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0086312:Forest [Geographic Area]
   799   C0442696:wake [Physiologic Function]
   799   C0585034:WAKE [Temporal Concept]

Phrase: "Winston-Salem,"

Phrase: "North Carolina 3 Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Wake Forest University School of Medicine,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0013227:Medicine, NOS [Pharmacologic Substance]
   799   C0025118:Medicine [Biomedical Occupation or Discipline]
   799   C0036375:School [Manufactured Object,Organization]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0086312:Forest [Geographic Area]
   799   C0442696:wake [Physiologic Function]
   799   C0585034:WAKE [Temporal Concept]

Phrase: "Winston-Salem,"

Phrase: "North Carolina 4 Department of Internal Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704729:Department [Organization]

Phrase: "Wake Forest University School of Medicine,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0013227:Medicine, NOS [Pharmacologic Substance]
   799   C0025118:Medicine [Biomedical Occupation or Discipline]
   799   C0036375:School [Manufactured Object,Organization]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0086312:Forest [Geographic Area]
   799   C0442696:wake [Physiologic Function]
   799   C0585034:WAKE [Temporal Concept]

Phrase: "Winston-Salem,"

Phrase: "North Carolina 5 Department of Public Health Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1512352:Health Sciences [Biomedical Occupation or Discipline]
   793   C0036397:Sciences [Occupation or Discipline]

Phrase: "Wake Forest University School of Medicine,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0013227:Medicine, NOS [Pharmacologic Substance]
   799   C0025118:Medicine [Biomedical Occupation or Discipline]
   799   C0036375:School [Manufactured Object,Organization]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0086312:Forest [Geographic Area]
   799   C0442696:wake [Physiologic Function]
   799   C0585034:WAKE [Temporal Concept]

Phrase: "Winston-Salem,"

Phrase: "North Carolina  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hepatocyte nuclear factor 4 (HNF4A),"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "the gene for the maturity-onset diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017337:Gene [Gene or Genome]

Phrase: "of the young type 1 monogenic form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0348078:Form [Qualitative Concept]
   804   C0376315:Form [Manufactured Object]
   804   C1522492:Form [Functional Concept]

Phrase: "of type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is within the type 2 diabeteslinked region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0441730:Type 2 [Classification]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "on chromosome 20q12-q13.1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1521057:20q12-q13.1 [Cell Component]
   902   C0008651:Chromosome 1 [Cell Component]
   861   C1521056:20q12-q13 [Cell Component]
   812   C0008633:Chromosome [Cell Component]
   812   C1521055:20q12 [Cell Component]
   812   C1549864:Q13 [Intellectual Product]

Phrase: "and"

Phrase: ","

Phrase: "consequently,"

Phrase: "is"

Phrase: "a positional candidate gene for type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1332838:Candidate Gene [Gene or Genome]
   767   C0079429:A Gene [Gene or Genome]
   767   C0314611:Gene type [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   731   C0887940:Gene Position [Molecular Function]

Phrase: "in the general population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.8: Previous studies have identified only a few rare coding mutations. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few rare coding mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.9: However, recent studies suggest that single nucleotide polymorphisms (SNPs) located near the P2 (-cell) promoter of HNF4A are associated with diabetes susceptibility. 

Phrase: "However,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that single nucleotide polymorphisms (SNPs)"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "located near the P2 (-cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1384585:P2 [Immunologic Factor]
   760   C1419693:P2 [Gene or Genome]
   760   C1539372:p2 [Gene or Genome]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "promoter of HNF4A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   716   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "are"

Phrase: "associated with diabetes susceptibility."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.10: In this study, we evaluated 23 SNPs spanning 111 kb including the HNF4A gene for association with type 2 diabetes in a collection of Caucasian type 2 diabetic patients with end-stage renal disease (n = 300) and control subjects (n = 310). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "23 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "111 kb"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the HNF4A gene for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0017337:Gene [Gene or Genome]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in a collection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516698:Collection [Functional Concept]
  1000   C1704814:Collection [Idea or Concept]
   928 E C1516695:Collected [Idea or Concept]

Phrase: "of Caucasian type 2 diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "with end-stage renal disease"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
  1000   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
  1000   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   923   C0679247:end stage disease [Disease or Syndrome]
           Terminal Disease
   861   C0022658:Renal disease [Disease or Syndrome]
   861   C0205088:End-stage [Temporal Concept]
       E   Terminal
   812   C0012634:Disease [Disease or Syndrome]
   812   C0022646:Renal [Body Part, Organ, or Organ Component]
   812   C0205390:Stage [Temporal Concept]
   812   C0444930:End [Spatial Concept]
   812   C1300072:Stage [Clinical Attribute]
   812   C1306673:Stage [Qualitative Concept]
   812   C2746065:End [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "(n = 300"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(n = 310"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.11: None of the individual SNPs were associated with type 2 diabetes in this collection of case subjects (P values ranging from 0.06 to 0.99). 

Phrase: "None of the individual SNPs"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0027361:Individual [Population Group]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0237401:Individual [Human]
   748   C0456148:None [Quantitative Concept]
   748   C0549184:None [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in this collection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516698:Collection [Functional Concept]
  1000   C1704814:Collection [Idea or Concept]
   928 E C1516695:Collected [Idea or Concept]

Phrase: "of case subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "ranging from 0.06"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 0.99"

Phrase: ")."
Processing 00000000.tx.12: However, haplotype analysis identifies significant differences between haplotype frequencies in type 2 diabetic case and control subjects (P = 0.013 to P < 0.001), with two uncommon "risk" haplotypes (2.4 and 2.2% of chromosomes) and two uncommon "protective" haplotypes (7.1 and 5.0% of chromosomes) accounting for the evidence of association. 

Phrase: "However,"

Phrase: "haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "identifies"

Phrase: "significant differences between haplotype frequencies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in type 2 diabetic case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0868928:Case [Functional Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(P = 0.013 to P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "with two uncommon """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522498:Uncommon [Qualitative Concept]

Phrase: "risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: """ haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "(2.4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "2.2% of chromosomes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0008662:2 chromosomes [Cell Component]
   770   C0008633:Chromosomes [Cell Component]
   770   C0740116:+2 [Quantitative Concept]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "two uncommon ""protective"" haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018591:Haplotypes [Organism Attribute]

Phrase: "(7.1"

Phrase: "and"

Phrase: "5.0% of chromosomes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0008668:5 chromosomes [Cell Component]
   819   C0444499:0/5 [Quantitative Concept]
   770   C0008633:Chromosomes [Cell Component]
   770   C0439084:>5 [Quantitative Concept]
   770   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "accounting for the evidence of association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0000938:Accounting [Occupational Activity]
Processing 00000000.tx.13: Our results suggest that type 2 diabetes linked to 20q1213 is a heterogeneous disease in which different populations may have different type 2 diabetes susceptibility loci. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "linked to 20q1213"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "is"

Phrase: "a heterogeneous disease in which different populations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012634:Disease [Disease or Syndrome]

Phrase: "may"

Phrase: "have"

Phrase: "different type 2 diabetes susceptibility loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.14: Several studies have provided evidence for linkage of type 2 diabetes to the long arm of chromosome 20 in Caucasians (15) and Asians (6,7), suggesting that one or more type 2 diabetes susceptibility loci are located on chromosome 20q. 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "provided evidence for linkage of type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "to the long arm"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0575519:Long arm [Finding]
   861   C0446516:Arm [Body Location or Region]
   861   C1269078:Arm [Body Part, Organ, or Organ Component]
   861   C1269612:Arm [Body Location or Region]
   805 E C0445456:Brachial [Spatial Concept]
   777 E C0206655:ARMS [Neoplastic Process]
   777 E C2681631:ARMS [Gene or Genome]

Phrase: "of chromosome 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008663:Chromosome 20 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "in Caucasians"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007457:Caucasians [Population Group]
  1000   C0043157:Caucasians [Population Group]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "Asians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078988:Asians [Population Group]

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more type 2 diabetes susceptibility loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1708726:Locus [Gene or Genome]

Phrase: "are"

Phrase: "located on chromosome 20q."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C2599609:20q chromosome [Cell or Molecular Dysfunction]
   770   C0008633:Chromosome [Cell Component]
   770   C1521048:20q [Nucleotide Sequence]
Processing 00000000.tx.15: Hepatocyte nuclear factor 4 (HNF4A) is a candidate gene within this linked region because mutations in HNF4A have been implicated in the maturity-onset diabetes of the young type 1 subtype of type 2 diabetes, a monogenic form of type 2 diabetes characterized by defective insulin secretion (8). 

Phrase: "Hepatocyte nuclear factor 4"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(HNF4A"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: "is"

Phrase: "a candidate gene within this linked region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1332838:Candidate Gene [Gene or Genome]
   774   C0079429:A Gene [Gene or Genome]
   774   C0314613:Linked gene [Genetic Function]
   748   C0017337:Gene [Gene or Genome]

Phrase: "because"

Phrase: "mutations in HNF4A"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]
   716   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in the maturity-onset diabetes of the young type 1 subtype"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   853   C1852093:Maturity-Onset Diabetes of the Young, Type 1 [Disease or Syndrome]
   819   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   819   C2984262:Maturity onset diabetes of the young [Functional Concept]
   770   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   767   C0011854:Diabetes Type 1 [Disease or Syndrome]
   753   C0441729:Type 1 [Classification]
   751   C1320657:Diabetes type [Finding]
   736   C0011847:Diabetes [Disease or Syndrome]
   736   C0011849:Diabetes [Disease or Syndrome]
   736   C0332162:Onset [Qualitative Concept]
   736   C0332239:Young [Temporal Concept]
   736   C0332307:Type [Qualitative Concept]
   736   C0449560:Subtype [Classification]
   736   C0449989:Maturity [Qualitative Concept]
   736   C0700597:Maturity [Temporal Concept]
   736   C1547052:*Type [Quantitative Concept]

Phrase: "of type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "a monogenic form of type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C3463805:Type of Form [Intellectual Product]
           form type
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "characterized by defective insulin secretion"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0332452:Defective [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1880022:Characterized [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.16: HNF4A is a member of the steroid/thyroid hormone receptor superfamily of transcription factors (9), and it interacts with regulatory elements in promoters and enhancers of genes involved in cholesterol, fatty acid, and glucose metabolism (10). 

Phrase: "HNF4A"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "a member of the steroid/thyroid hormone receptor superfamily of transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0680022:member [Population Group]
   736   C2698041:Member [Professional or Occupational Group]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "interacts with regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0013879:Elements [Element, Ion, or Isotope]
   770   C0220905:regulatory [Regulation or Law]
   770   C1704735:Regulatory [Conceptual Entity]
   737 E C1705248:Element [Conceptual Entity]

Phrase: "in promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "enhancers of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "involved in cholesterol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   790   C1314939:Involved [Functional Concept]

Phrase: "fatty acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015684:Fatty acid [Lipid]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.17: Thirteen exons have been identified in HNF4A, and alternative splicing of these exons results in at least nine isoforms of the gene. 

Phrase: "Thirteen exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "have"

Phrase: "been"

Phrase: "identified in HNF4A,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   833   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205396:Identified [Qualitative Concept]
   753   C0227525:Hepatocyte [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1521761:Factor [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "alternative splicing of these exons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0002345:Alternative Splicing [Genetic Function]
   760   C0035687:Splicing [Genetic Function]
   760   C2610186:splicing [Genetic Function]

Phrase: "results in"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1274040:Result [Functional Concept]
   833   C1546471:Result [Idea or Concept]
   833   C2825142:Result [Finding]

Phrase: "at least nine isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "of the gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.18: The transcription of three of these isoforms is driven by an alternate promoter known as P2, which is located 45.5 kb upstream of the P1 promoter (11,12). 

Phrase: "The transcription of three of these isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "driven by an alternate promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0332270:alternate [Functional Concept]
   760   C1523987:Alternate [Conceptual Entity]
   726   C0013126:Drive [Mental Process]

Phrase: "known as P2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205309:Known [Qualitative Concept]
   790   C1384585:P2 [Immunologic Factor]
   790   C1419693:P2 [Gene or Genome]
   790   C1539372:p2 [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "located"

Phrase: "45.5 kb upstream of the P1 promoter"

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.19: Recent studies suggest that although both promoters function in pancreatic -cells (13), it is the P2 promoter that primarily drives transcription in these cells (11,12). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "although"

Phrase: "both promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "function in pancreatic -cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   819   C0007613:cells function [Cell Function]
   819   C0232786:Pancreatic function [Organ or Tissue Function]
   770   C0007634:Cells [Cell]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "the P2 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that primarily"

Phrase: "drives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "transcription in these cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.20: In previous studies (14,15), we surveyed the coding region of HNF4A and conserved enhancer-like elements in the distal HNF4A promoter, finding no evidence for significant association to type 2 diabetes in the general population. 

Phrase: "In previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(14,"

Phrase: "15"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "surveyed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0038951:Survey [Intellectual Product]

Phrase: "the coding region of HNF4A"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0079941:Coding Region [Gene or Genome]
   744   C0009219:Coding [Occupational Activity]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   711 E C0805701:Code [Intellectual Product]

Phrase: "and"

Phrase: "conserved enhancer-like elements in the distal HNF4A promoter,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   766   C1511993:Distal Enhancer Elements [Nucleotide Sequence]
   751   C0014290:Enhancer Elements [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0013879:Elements [Element, Ion, or Isotope]
   703 E C1705248:Element [Conceptual Entity]

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "no evidence for significant association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "to type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in the general population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683971:General Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.21: Recently, several groups have evaluated single nucleotide polymorphisms (SNPs) in the P2 region for association with type 2 diabetes. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "several groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "have"

Phrase: "evaluated single nucleotide polymorphisms"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: ")"

Phrase: "in the P2 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "for association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.22: These reports suggest that four SNPs in a 10.7-kb region encompassing the P2 promoter are significantly associated with type 2 diabetes disease status in subjects from Finnish type 2 diabetic families (16) and Ashkenazi Jewish type 2 diabetic families (17).  

Phrase: "These reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that four SNPs in a 10.7-kb region"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   775   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   738   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0032529:polymorphisms [Genetic Function]
   738   C0037179:Single [Population Group]
   738   C0087136:single [Finding]
   738   C0205171:Single [Quantitative Concept]
   704 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "encompassing"

Phrase: "the P2 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "significantly"

Phrase: "associated with type 2 diabetes disease status"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   814   C0011860:Type 2 Diabetes [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0441730:Type 2 [Classification]
   774   C0243083:associated disease [Pathologic Function]
   774   C0457464:disease type [Intellectual Product]
   774   C1317301:Diabetes status [Organism Attribute]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C0449438:Status [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
   746   C1425076:MALS-2 [Gene or Genome]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "from Finnish type 2 diabetic families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "Ashkenazi Jewish type 2 diabetic families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0015576:Families [Family Group]
   799   C1704727:Family [Conceptual Entity]
   716 E C0241888:Familial [Functional Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.23: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The samples evaluated in this study consisted of a collection of 300 unrelated Caucasian type 2 diabetic patients with end-stage renal disease (ESRD), and a corresponding collection of 310 randomly ascertained unrelated Caucasian subjects with no known history of diabetes. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "evaluated in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220825:Evaluated [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "consisted of a collection of 300 unrelated Caucasian type 2 diabetic patients"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   766   C0445613:Type of collection [Intellectual Product]
   753   C0441730:Type 2 [Classification]
   736   C0007457:Caucasian [Population Group]
   736   C0030705:Patients [Patient or Disabled Group]
   736   C0043157:Caucasian [Population Group]
   736   C0241863:DIABETIC [Finding]
   736   C0332307:Type [Qualitative Concept]
   736   C0445356:Unrelated [Finding]
   736   C1516698:Collection [Functional Concept]
   736   C1547052:*Type [Quantitative Concept]
   736   C1704623:Unrelated [Qualitative Concept]
   736   C1704814:Collection [Idea or Concept]
   734   C1550335:Patient type [Classification]
   703   C0332529:CONSIST [Qualitative Concept]

Phrase: "with end-stage renal disease (ESRD),"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
  1000   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
  1000   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   923   C0679247:end stage disease [Disease or Syndrome]
           Terminal Disease
   861   C0022658:Renal disease [Disease or Syndrome]
   861   C0205088:End-stage [Temporal Concept]
       E   Terminal
   812   C0012634:Disease [Disease or Syndrome]
   812   C0022646:Renal [Body Part, Organ, or Organ Component]
   812   C0205390:Stage [Temporal Concept]
   812   C0444930:End [Spatial Concept]
   812   C1300072:Stage [Clinical Attribute]
   812   C1306673:Stage [Qualitative Concept]
   812   C2746065:End [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "a corresponding collection of 310 randomly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1516698:Collection [Functional Concept]
   753   C1704814:Collection [Idea or Concept]

Phrase: "ascertained"

Phrase: "unrelated Caucasian subjects with no known history of diabetes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]
Processing 00000000.tx.24: Both sample collections were recruited simultaneously. 

Phrase: "Both sample collections"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0200345:sample collection [Laboratory Procedure]
   861   C0600644:Collections [Intellectual Product]
   861   C1516698:Collection [Functional Concept]
   861   C1704814:Collection [Idea or Concept]
   777 E C1516695:Collected [Idea or Concept]

Phrase: "were"

Phrase: "recruited"

Phrase: "simultaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]
Processing 00000000.tx.25: Ascertainment and recruitment criteria of these collections have been described previously in detail (1823). 

Phrase: "Ascertainment"

Phrase: "and"

Phrase: "recruitment criteria of these collections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243161:criteria [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously in detail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1522508:Detail [Qualitative Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "(1823"

Phrase: ")."
Processing 00000000.tx.26: Case subjects were recruited on the basis of a diagnosis of type 2 diabetes and ESRD. 

Phrase: "Case subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "recruited on the basis of a diagnosis of type 2 diabetes"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   775   C0011860:Type 2 Diabetes [Disease or Syndrome]
   756   C0441730:Type 2 [Classification]
   754   C1320657:Diabetes type [Finding]
   754   C1550351:Diagnosis Type [Classification]
   738   C0011847:Diabetes [Disease or Syndrome]
   738   C0011849:Diabetes [Disease or Syndrome]
   738   C0011900:Diagnosis [Finding]
   738   C0332307:Type [Qualitative Concept]
   738   C1527178:Basis [Functional Concept]
   738   C1547052:*Type [Quantitative Concept]
   738   C1704338:diagnosis [Qualitative Concept]
   738   C1704656:DIAGNOSIS [Research Activity]
   738   C1874451:Basis [Pharmacologic Substance]

Phrase: "and"

Phrase: "ESRD."
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
  1000   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
  1000   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   923   C0679247:end stage disease [Disease or Syndrome]
           Terminal Disease
   861   C0022658:Renal disease [Disease or Syndrome]
   861   C0205088:End-stage [Temporal Concept]
       E   Terminal
   812   C0012634:Disease [Disease or Syndrome]
   812   C0022646:Renal [Body Part, Organ, or Organ Component]
   812   C0205390:Stage [Temporal Concept]
   812   C0444930:End [Spatial Concept]
   812   C1300072:Stage [Clinical Attribute]
   812   C1306673:Stage [Qualitative Concept]
   812   C2746065:End [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.27: These case subjects were not derived from the family collection that previously showed evidence of linkage to 20q (1) but were recruited using identical clinical criteria. 

Phrase: "These case subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "derived from the family collection"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C2700055:Family Collection [Classification]
   760   C0015576:Family [Family Group]
   760   C1441547:Derived [Qualitative Concept]
   760   C1516698:Collection [Functional Concept]
   760   C1704727:Family [Conceptual Entity]
   760   C1704814:Collection [Idea or Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "that previously"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "to 20q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521048:20q [Nucleotide Sequence]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "but"

Phrase: "were"

Phrase: "recruited"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "identical clinical criteria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.28: The type 2 diabetic ESRD subjects were 52% female and had a mean age at diagnosis of diabetes of 46.5  12.8 years, mean BMI at recruitment of 28.5  7.0 kg/m2, mean maximum reported BMI of 36.1  8.3 kg/m2, mean duration of diabetes >15 years, and mean HbA1c of 8.6%. 

Phrase: "The type 2 diabetic ESRD subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
   711   C0457464:type disease [Intellectual Product]

Phrase: "were"

Phrase: "52% female"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: "and"

Phrase: "had"

Phrase: "a mean age at diagnosis of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1828181:Age at diagnosis [Clinical Attribute]
   748   C0001779:Age [Organism Attribute]

Phrase: "of 46.5  12.8 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "mean BMI at recruitment"

Phrase: "of 28.5  7.0 kg/m2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456689:kg/m2 [Quantitative Concept]
   799   C0457242:m2 [Quantitative Concept]

Phrase: "mean maximum"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0806909:Maximum [Quantitative Concept]
   861   C1552615:maximum [Quantitative Concept]
   861   C2826546:MAXIMUM [Quantitative Concept]
   789 E C0205289:Maximal [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "BMI of 36.1  8.3 kg/m2,"

Phrase: "mean duration of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]

Phrase: ">15 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "mean HbA1c of 8.6%."
Processing 00000000.tx.29: Control subjects were 67% female, had a mean age of 45.8 years, and a mean BMI (from self-reported height and weight) of 25.7 kg/m2. 

Phrase: "Control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "67% female,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: "had"

Phrase: "a mean age of 45.8 years,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1510829:Age-Years [Temporal Concept]
   748   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "a mean BMI (from self-reported height"

Phrase: "and"

Phrase: "weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005910:weight [Organism Attribute]
  1000   C0043100:Weight [Quantitative Concept]
  1000   C1305866:weight [Diagnostic Procedure]
  1000   C1705104:Weight [Idea or Concept]

Phrase: ")"

Phrase: "of 25.7 kg/m2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456689:kg/m2 [Quantitative Concept]
   812   C0457242:m2 [Quantitative Concept]
Processing 00000000.tx.30: SNP selection and genotyping. 

Phrase: "SNP selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "and"

Phrase: "genotyping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.31: Sixteen SNPs used in this study were selected from the dbSNP public database (rs2868093, rs6073418, rs717248, rs717247, rs736820, rs736822, rs736824, rs745975, rs736823, rs1885088, rs1885089, rs3212198, rs1028583, rs1028584, rs2273618, and rs911358) and were mapped to unique locations in and around the HNF4A gene. 

Phrase: "Sixteen SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "selected from the dbSNP public database"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0242356:Database [Intellectual Product]
   753   C0993637:Data Base [Intellectual Product]
   753   C1710090:dbSNP [Intellectual Product]
   719   C1707391:Select [Activity]

Phrase: "(rs2868093,"

Phrase: "rs6073418,"

Phrase: "rs717248,"

Phrase: "rs717247,"

Phrase: "rs736820,"

Phrase: "rs736822,"

Phrase: "rs736824,"

Phrase: "rs745975,"

Phrase: "rs736823,"

Phrase: "rs1885088,"

Phrase: "rs1885089,"

Phrase: "rs3212198,"

Phrase: "rs1028583,"

Phrase: "rs1028584,"

Phrase: "rs2273618,"

Phrase: "and"

Phrase: "rs911358"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "mapped to unique locations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   786   C1512989:Map Location [Conceptual Entity]
   770   C0450429:locations [Spatial Concept]
   770   C1710548:Unique [Qualitative Concept]
   737   C0024779:Map [Manufactured Object]
   737 E C1515974:Location [Body Location or Region]
   737   C1706473:Map [Conceptual Entity]

Phrase: "in"

Phrase: "and around the HNF4A gene."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   800   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C0227525:Hepatocyte [Cell]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1515981:And [Idea or Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.32: Seven additional dbSNPs (rs4810424, rs1884613, rs1884614, rs2144908, rs2425637, rs2425640, andrs3818247) located in and around the HNF4A gene were selected on the basis of previous reports of association with type 2 diabetes in Finnish (16) and/or Ashkenazi (17) populations. 

Phrase: "Seven additional dbSNPs"

Phrase: "(rs4810424,"

Phrase: "rs1884613,"

Phrase: "rs1884614,"

Phrase: "rs2144908,"

Phrase: "rs2425637,"

Phrase: "rs2425640,"

Phrase: "andrs3818247"

Phrase: ")"

Phrase: "located in"

Phrase: "and around the HNF4A gene"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   800   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C0227525:Hepatocyte [Cell]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1515981:And [Idea or Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "selected on the basis of previous reports of association"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   742   C0004083:Association [Mental Process]
   742   C0205156:Previous [Temporal Concept]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0684224:Reports [Intellectual Product]
   742   C0699792:association [Social Behavior]
   742   C0700287:reports [Health Care Activity]
   742   C1527178:Basis [Functional Concept]
   742   C1552607:previous [Temporal Concept]
   742   C1874451:Basis [Pharmacologic Substance]
   708   C1707391:Select [Activity]
   708 E C3273238:Report [Intellectual Product]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in Finnish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711254:Finnish [Population Group]

Phrase: "(16"

Phrase: ")"

Phrase: "and/or"

Phrase: "Ashkenazi"

Phrase: "(17"

Phrase: ")"

Phrase: "populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.33: SNP genotyping was performed on a Sequenom MassArray Genotyping System (Sequenom, San Diego, CA) as previously described (24). 

Phrase: "SNP genotyping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285573:Genotyping [Laboratory Procedure]

Phrase: "was"

Phrase: "performed on a Sequenom MassArray Genotyping System"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0449913:System [Functional Concept]
   748   C0884358:Performed [Functional Concept]
   748   C1285573:Genotyping [Laboratory Procedure]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   714 E C0017431:Genotype [Organism Attribute]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Sequenom,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.34: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.35: Pearsons test of homogeneity of proportions was applied to analyze allele frequency differences between diabetic and nondiabetic subjects. 

Phrase: "Pearsons"

Phrase: "test of homogeneity of proportions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1881065:Homogeneity [Qualitative Concept]
   726   C1709707:Proportion [Quantitative Concept]

Phrase: "was"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "allele frequency differences between diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "nondiabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.36: The SNP-Analysis software package (http://www.fhcrc.org/labs/Kruglyak/Downloads) was used to evaluate SNPs for Hardy-Weinberg equilibrium and to calculate pairwise linkage disequilibrium (LD) statistics. 

Phrase: "The SNP-Analysis software package"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013194:Package [Medical Device]
   812   C2700580:Package [Manufactured Object]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.fhcrc.org/labs/Kruglyak/Downloads"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "SNPs for Hardy-Weinberg equilibrium"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "pairwise linkage disequilibrium (LD) statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0038215:Statistics [Occupation or Discipline]
   812   C0600673:Statistics [Intellectual Product]
   779 E C2348149:Statistic [Quantitative Concept]
   779 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.37: Within the regions of strongest LD, HAPLO.SCORE (25 and http://www.mayo.edu/statgen/) and Dandelion (26) were used to estimate haplotypes and to test for association of these haplotypes within the case-control population. 

Phrase: "Within the regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "of strongest LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "HAPLO.SCORE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Score [Quantitative Concept]

Phrase: "(25"

Phrase: "and"

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.mayo.edu/statgen/"

Phrase: ")"

Phrase: "and"

Phrase: "Dandelion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0440015:DANDELION [Organic Chemical,Pharmacologic Substance]
  1000   C0877851:Dandelion [Plant]
  1000   C0939896:dandelion [Pharmacologic Substance]
  1000   C1093500:Dandelion [Plant]
  1000   C1256220:dandelion [Pharmacologic Substance]

Phrase: "(26"

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for association of these haplotypes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0004083:Association [Mental Process]
   753   C0018591:Haplotypes [Organism Attribute]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "within the case-control population."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0032662:control population [Occupation or Discipline]
   901   C0872128:case control [Health Care Activity]
   827   C0032659:Population [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1257890:Population [Population Group]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.38: Direct sequencing. 

Phrase: "Direct sequencing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.39: The coding regions encompassed by specific haplotypes were sequenced to assess whether coding mutations contribute to the observed haplotype associations. 

Phrase: "The coding regions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "encompassed by specific haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018591:Haplotypes [Organism Attribute]
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "coding mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "contribute to the observed haplotype associations."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0004083:Associations [Mental Process]
   753   C0018591:Haplotype [Organism Attribute]
   753   C1441672:Observed [Functional Concept]
   753   C1880177:Contribute [Activity]
   719 E C0439849:Association [Qualitative Concept]
   719 E C0596306:Association [Phenomenon or Process]
   719 E C0699792:association [Social Behavior]
Processing 00000000.tx.40: Specifically, the P2 promoter region and alternate exon 1d were sequenced in 27 Caucasian type 2 diabetic case subjects with either of the risk haplotypes and in an equal number of Caucasian control subjects with neither of the risk haplotypes. 

Phrase: "Specifically,"

Phrase: "the P2 promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "alternate exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "were"

Phrase: "sequenced in 27 Caucasian type 2 diabetic case"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0441730:Type 2 [Classification]
   744   C0007457:Caucasian [Population Group]
   744   C0043157:Caucasian [Population Group]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C0868928:Case [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   711   C0004793:Sequence [Nucleotide Sequence]
   711   C0162326:Sequence [Nucleotide Sequence]
   711   C0162327:Sequence [Nucleotide Sequence]
   711   C1519249:Sequence [Functional Concept]

Phrase: "subjects with either of the risk haplotypes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0035647:Risk [Qualitative Concept]
   748   C0681850:Subject [Group]
   748   C1550501:{Subject} [Idea or Concept]
   748   C1706203:Subject [Idea or Concept]
   748   C2349001:Subject [Human]
   748   C2697811:Subject [Functional Concept]

Phrase: "and in an equal number of Caucasian control subjects"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   742   C0007457:Caucasian [Population Group]
   742   C0043157:Caucasian [Population Group]
   742   C0205163:Equal [Qualitative Concept]
   742   C0237753:*Number [Quantitative Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1515981:And [Idea or Concept]
   742   C1549782:Equal [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "with neither"

Phrase: "of the risk haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.41: Exon 4 was sequenced in 16 Caucasian control subjects bearing either of the protective haplotypes and in an equal number of Caucasian type 2 diabetic case subjects with neither of the protective haplotypes. 

Phrase: "Exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "sequenced in 16 Caucasian control subjects"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   753   C0007457:Caucasian [Population Group]
   753   C0043157:Caucasian [Population Group]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0004793:Sequence [Nucleotide Sequence]
   719   C0162326:Sequence [Nucleotide Sequence]
   719   C0162327:Sequence [Nucleotide Sequence]
   719   C0681850:Subject [Group]
   719   C1519249:Sequence [Functional Concept]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "either of the protective haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0018591:Haplotypes [Organism Attribute]

Phrase: "and in an equal number of Caucasian type 2 diabetic case"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   756   C0441730:Type 2 [Classification]
   754   C1882124:Number Type [Conceptual Entity]
   738   C0007457:Caucasian [Population Group]
   738   C0043157:Caucasian [Population Group]
   738   C0205163:Equal [Qualitative Concept]
   738   C0237753:*Number [Quantitative Concept]
   738   C0241863:DIABETIC [Finding]
   738   C0332307:Type [Qualitative Concept]
   738   C0449788:Number [Quantitative Concept]
   738   C0868928:Case [Functional Concept]
   738   C1515981:And [Idea or Concept]
   738   C1547052:*Type [Quantitative Concept]
   738   C1549782:Equal [Idea or Concept]
   738   C1706255:CASE [Medical Device]
   738   C1706256:Case [Conceptual Entity]

Phrase: "subjects with neither of the protective haplotypes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0681850:Subject [Group]
   748   C1550501:{Subject} [Idea or Concept]
   748   C1706203:Subject [Idea or Concept]
   748   C2349001:Subject [Human]
   748   C2697811:Subject [Functional Concept]
Processing 00000000.tx.42: In addition, SNP rs1884613 and the surrounding genomic region were sequenced in 96 Caucasian type 2 diabetic case subjects to confirm individual genotypes assigned by the Sequenom system at this particular SNP. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "SNP rs1884613"

Phrase: "and"

Phrase: "the surrounding genomic region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0017428:Genomic [Gene or Genome]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0887950:genomic [Biomedical Occupation or Discipline]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "sequenced in 96 Caucasian type 2 diabetic case"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0441730:Type 2 [Classification]
   744   C0007457:Caucasian [Population Group]
   744   C0043157:Caucasian [Population Group]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C0868928:Case [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   711   C0004793:Sequence [Nucleotide Sequence]
   711   C0162326:Sequence [Nucleotide Sequence]
   711   C0162327:Sequence [Nucleotide Sequence]
   711   C1519249:Sequence [Functional Concept]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "individual genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "assigned by the Sequenom system"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0449913:System [Functional Concept]
   760   C1516050:Assigned [Functional Concept]
   760   C1552601:assigned [Intellectual Product]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "at this particular SNP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]
Processing 00000000.tx.43: All samples were sequenced with both forward and reverse primers using the BigDye Terminator v.1.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA) according to the manufacturers instructions. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "sequenced with both forward"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439780:Forward [Spatial Concept]
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "reverse primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BigDye Terminator v.1.1 Cycle Sequencing Kit (Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA) according to the manufacturers instructions."
Processing 00000000.tx.44: The sequencing reactions were then analyzed with the Applied Biosystems 3730xl DNA sequencer (Applied Biosystems, Foster City, CA).  

Phrase: "The sequencing reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed with the Applied Biosystems 3730xl DNA sequencer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0185125:Applied [Health Care Activity]
   744   C0936012:Analyzed [Research Activity]

Phrase: "(Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.45: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  In this study, we evaluated 23 SNPs covering a 111-kb genomic region spanning distal to the P2 promoter through the HNF4A coding sequence (Fig. 1). 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "23 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "a 111-kb genomic region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0017428:Genomic [Gene or Genome]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C0887950:genomic [Biomedical Occupation or Discipline]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "distal to the P2 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205108:Distal [Spatial Concept]

Phrase: "through the HNF4A coding sequence"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   827   C0079941:Coding Sequence [Gene or Genome]
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0009219:Coding [Occupational Activity]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   766 E C0805701:Code [Intellectual Product]
   734   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.46: All SNPs were located in noncoding regions except rs736823 (in exon 2), resulting in a H98Y amino acid change. 

Phrase: "All SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "located in noncoding regions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "except rs736823"

Phrase: "("

Phrase: "in exon 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "resulting in a H98Y amino acid change."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   814   C1953353:Amino acid change [Finding]
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0332294:Resulting in [Functional Concept]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1705241:Change [Quantitative Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]
Processing 00000000.tx.47: The average spacing between SNPs was 5 kb, with inter-SNP distances ranging from 90 bp to 23.5 kb. 

Phrase: "The average spacing between SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710137:Spacing [Quantitative Concept]

Phrase: "was"

Phrase: "5 kb,"

Phrase: "with"

Phrase: "inter-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205103:Inter- [Spatial Concept]
  1000   C1548610:Inter [Temporal Concept]

Phrase: "SNP distances"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0012751:distances [Quantitative Concept]
   777 E C0443203:Distant [Spatial Concept]

Phrase: "ranging from 90 bp"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 23.5 kb."
Processing 00000000.tx.48: Included in this evaluation were the four SNPs showing significant association in both the Finnish (16) and Ashkenazi Jewish (17) populations (rs4810424, rs1884613, rs1884614, and rs2144908). 

Phrase: "Included in this evaluation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0220825:Evaluation [Functional Concept]
   770   C0332257:included [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "were"

Phrase: "the four SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant association in both"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "the Finnish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711254:Finnish [Population Group]

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "Ashkenazi Jewish"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022422:Jewish [Idea or Concept]
   861   C0178443:Jewish [Population Group]

Phrase: "(17"

Phrase: ")"

Phrase: "populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "(rs4810424,"

Phrase: "rs1884613,"

Phrase: "rs1884614,"

Phrase: "and"

Phrase: "rs2144908"

Phrase: ")."
Processing 00000000.tx.49: In addition, the SNPs we evaluated included two SNPs showing association in the Finnish population only (rs2425637 and rs2425640) and two SNPs showing association in the Ashkenazi Jewish population only (rs1028583 and rs3818247). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "included two SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   804   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0032529:polymorphisms [Genetic Function]
   804   C0037179:Single [Population Group]
   804   C0087136:single [Finding]
   804   C0205171:Single [Quantitative Concept]
   771 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "association in the Finnish population only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "(rs2425637"

Phrase: "and"

Phrase: "rs2425640"

Phrase: ")"

Phrase: "and"

Phrase: "two SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "association in the Ashkenazi Jewish population only"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "(rs1028583"

Phrase: "and"

Phrase: "rs3818247"

Phrase: ")."
Processing 00000000.tx.50: View larger version (10K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.51: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.52: Genomic map of the HNF4A gene with the locations of the 23 genotyped SNPs. 

Phrase: "Genomic map of the HNF4A gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C3540819:MAP-4 [Gene or Genome]
   742   C0024779:Map [Manufactured Object]
   742   C1706473:Map [Conceptual Entity]

Phrase: "with the locations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0450429:locations [Spatial Concept]
   966 E C1515974:Location [Body Location or Region]

Phrase: "of the 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "SNPs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.53: The labeled shaded regions are exons, numbered 110. 

Phrase: "The labeled shaded regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "numbered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbered [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "110."
Processing 00000000.tx.54: The unlabeled shaded regions indicate evolutionarily conserved regions, as identified previously (15). 

Phrase: "The unlabeled shaded regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "indicate"

Phrase: "evolutionarily conserved regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "as"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "previously"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.55: The ruler along the bottom represents the relative location and spacing of SNPs in kilobases within the 111.23-kb region containing HNF4A.  

Phrase: "The ruler along the bottom"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522637:Ruler [Medical Device]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the relative location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "and"

Phrase: "spacing of SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710137:Spacing [Quantitative Concept]

Phrase: "in kilobases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0582519:kilobase [Quantitative Concept]

Phrase: "within the 111.23-kb region containing HNF4A."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   849   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   827   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0227525:Hepatocyte [Cell]
   791   C0521447:Nuclear [Spatial Concept]
   791   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   791   C1521761:Factor [Functional Concept]
   791   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.56: The 23 SNPs were genotyped in a collection of Caucasian type 2 diabetic ESRD case subjects (n = 300) and control subjects (n = 310), and single SNP association analysis was performed. 

Phrase: "The 23 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "genotyped in a collection"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1516698:Collection [Functional Concept]
   770   C1704814:Collection [Idea or Concept]
   737   C0017431:Genotype [Organism Attribute]

Phrase: "of Caucasian type 2 diabetic ESRD case subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "(n = 300"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(n = 310"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "single SNP association analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.57: In the control population, rs2425637 (P = 0.009) and rs2425640 (P = 7.6 x 109) did not conform to Hardy-Weinberg equilibrium. 

Phrase: "In the control population,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "rs2425637"

Phrase: "(P = 0.009"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "rs2425640"

Phrase: "(P = 7.6 x 109"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "conform to Hardy-Weinberg equilibrium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]
Processing 00000000.tx.58: Rs2425640 is one of the SNPs for which association with type 2 diabetes in the Ashkenazi Jewish population was observed. 

Phrase: "Rs2425640"

Phrase: "is"

Phrase: "one of the SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "for which association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "in the Ashkenazi Jewish population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.59: Single SNP association analysis is summarized in Table 1, which shows the SNP identifier, the relevant alleles for each SNP, frequencies in case and control subjects, and P values from the test for allelic association. 

Phrase: "Single SNP association analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "is"

Phrase: "summarized in Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the SNP identifier,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0600091:Identifier [Intellectual Product]
   861   C1554104:Identifier [Idea or Concept]
   861   C1554159:Identifier [Idea or Concept]

Phrase: "the relevant alleles for each SNP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Alleles [Gene or Genome]

Phrase: "frequencies in case"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   790   C0439603:Frequencies [Temporal Concept]
   756 E C0376249:frequency [Quantitative Concept]
   756 E C0871396:Frequency [Quantitative Concept]
   756 E C1561548:Frequency [Qualitative Concept]
   756 E C1705502:Frequency [Quantitative Concept]
   706 E C0332183:Frequent [Temporal Concept]

Phrase: "and"

Phrase: "control subjects,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "P values from the test"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1709380:P-Value [Quantitative Concept]
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "for allelic association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]
Processing 00000000.tx.60: This analysis revealed little or no evidence of association between these 23 SNPs and type 2 diabetes or even a suggestive trend (P values between 0.06 and 0.99). 

Phrase: "This analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "between these 23 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "even"

Phrase: "a suggestive trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521798:trend [Temporal Concept]

Phrase: "(P values between 0.06"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   773   C1709380:P-Value [Quantitative Concept]
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "0.99"

Phrase: ")."
Processing 00000000.tx.61: The lowest P value is with rs717248, which was not an associated SNP in the Finnish and Ashkenazi studies. 

Phrase: "The lowest P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "is with rs717248,"

Phrase: "which"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an associated SNP in the Finnish"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0752046:SNP [Nucleotide Sequence]
   753   C1527094:SNP [Conceptual Entity]

Phrase: "and"

Phrase: "Ashkenazi studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.62: View this table: [in this window] [in a new window]  TABLE 1 Association analysis for HNF4A SNPs in Caucasian type 2 diabetic ESRD subjects and Caucasian control subjects  Even if no individual SNPs in HNF4A are associated with disease status, it may be possible to identify HNF4A haplotypes that are significantly associated with increased or decreased type 2 diabetes risk (27). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Association analysis for HNF4A SNPs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   768   C3536614:Single nucleotide polymorphism analysis [Laboratory Procedure]
   751   C0085801:Analysis, Factor [Quantitative Concept]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1524024:analysis [Functional Concept]
   734   C0796451:polymorphism analysis [Diagnostic Procedure]

Phrase: "in Caucasian type 2 diabetic ESRD subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   758   C0681850:Subject [Group]
   758   C1550501:{Subject} [Idea or Concept]
   758   C1706203:Subject [Idea or Concept]
   758   C2349001:Subject [Human]
   758   C2697811:Subject [Functional Concept]
   700   C0457464:type disease [Intellectual Product]

Phrase: "and"

Phrase: "Caucasian control subjects  Even"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "if"

Phrase: "no individual SNPs in HNF4A"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   782   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   739   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0032529:polymorphisms [Genetic Function]
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0205171:Single [Quantitative Concept]
   706 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "associated with disease status,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0449438:Status [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "identify"

Phrase: "HNF4A haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0018591:Haplotypes [Organism Attribute]
   771   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "are"

Phrase: "significantly"

Phrase: "associated with increased"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "decreased type 2 diabetes risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1171304:diabetes risk [Quantitative Concept]
   804   C0035647:Risk [Qualitative Concept]
   717   C0011860:Type 2 Diabetes [Disease or Syndrome]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.63: Therefore, LD and the haplotype structure of HNF4A were examined to determine whether specific SNP haplotypes were associated with type 2 diabetes in our population. 

Phrase: "Therefore,"

Phrase: "LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "the haplotype structure of HNF4A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0682613:hepatocyte structure [Cell]
   767   C1518439:Nuclear Structure [Cell Component]
   744   C0678594:Structure [Spatial Concept]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "specific SNP haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in our population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.64: Inter-SNP D' values were calculated for the HNF4A gene region (Fig. 2). 

Phrase: "Inter-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205103:Inter- [Spatial Concept]
  1000   C1548610:Inter [Temporal Concept]

Phrase: "SNP D' values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated for the HNF4A gene region"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   818   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   790   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0017337:Gene [Gene or Genome]
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C0227525:Hepatocyte [Cell]
   742   C0444686:Calculated [Functional Concept]
   742   C0521447:Nuclear [Spatial Concept]
   742   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.65: When D' >0.7 was used to define strong disequilibrium, two six-SNP blocks were identified. 

Phrase: "When"

Phrase: "D' >"

Phrase: "0.7"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "strong disequilibrium,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "two six-SNP blocks"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0028778:blocks [Pathologic Function]
   812   C0332206:Blocks [Functional Concept]
   812   C1533157:Blocks [Substance]
   779 E C1706084:Block [Geographic Area]
   779 E C2828370:Block [Quantitative Concept]
   729 E C2983591:BLOCKED [Research Activity]

Phrase: "were"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.66: The first block, beginning with rs2868093 20 kb upstream of P2 and ending with rs6073418 17 kb downstream of P2, represents the block of strongest disequilibrium, which spans a region of 36.8 kb. 

Phrase: "The first block,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "beginning with rs2868093 20 kb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439659:Beginning [Temporal Concept]

Phrase: "upstream of P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "and"

Phrase: "ending with rs6073418 17 kb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444930:ending [Spatial Concept]
   760   C2746065:Ending [Temporal Concept]

Phrase: "downstream of P2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the block of strongest disequilibrium,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0028778:Block [Pathologic Function]
   760   C0332206:Block [Functional Concept]
   760   C1533157:Block [Substance]
   760   C1706084:Block [Geographic Area]
   760   C2828370:Block [Quantitative Concept]

Phrase: "which"

Phrase: "spans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "a region of 36.8 kb."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
Processing 00000000.tx.67: The second block of more modest disequilibrium, beginning with rs1885088 in intron 3 and ending with rs2273618 in intron 7, covers a 13.5-kb region. 

Phrase: "The second block of more modest disequilibrium,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0028778:Block [Pathologic Function]
   748   C0332206:Block [Functional Concept]
   748   C1533157:Block [Substance]
   748   C1706084:Block [Geographic Area]
   748   C2828370:Block [Quantitative Concept]

Phrase: "beginning with rs1885088"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439659:Beginning [Temporal Concept]

Phrase: "in intron 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "ending with rs2273618"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444930:ending [Spatial Concept]
   790   C2746065:Ending [Temporal Concept]

Phrase: "in intron 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "covers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0180153:cover [Medical Device]
  1000   C1707529:Cover [Medical Device]
  1000   C1999244:Cover [Functional Concept]

Phrase: "a 13.5-kb region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.68: Marker to marker D' values between SNPs in the first block and SNPs in the second block indicate that the two blocks are not in LD with each other. 

Phrase: "Marker to marker D' values"

Phrase: "between SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the first block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0028778:Block [Pathologic Function]
   861   C0332206:Block [Functional Concept]
   861   C1533157:Block [Substance]
   861   C1706084:Block [Geographic Area]
   861   C2828370:Block [Quantitative Concept]
   789 E C2983591:BLOCKED [Research Activity]

Phrase: "and"

Phrase: "SNPs in the second block"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "the two blocks"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0028778:blocks [Pathologic Function]
   861   C0332206:Blocks [Functional Concept]
   861   C1533157:Blocks [Substance]
   827 E C1706084:Block [Geographic Area]
   827 E C2828370:Block [Quantitative Concept]
   777 E C2983591:BLOCKED [Research Activity]

Phrase: "are"

Phrase: "not in LD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1518422:Not [Functional Concept]

Phrase: "with each other."
Processing 00000000.tx.69: View larger version (75K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(75K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.70: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.71: Marker-to-marker D' plots for the 23 HNF4A SNPs. 

Phrase: "Marker-to-marker"

Phrase: "D'"

Phrase: "plots for the 23 HNF4A SNPs."
Processing 00000000.tx.72: Inter-SNP D' values are graphically represented using the Graphical Overview of LD (GOLD) software package, which generates the color-coded plot of the pairwise disequilibrium statistics with horizontal and vertical axes that are scaled according to the inter-SNP distances (31).  

Phrase: "Inter-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205103:Inter- [Spatial Concept]
  1000   C1548610:Inter [Temporal Concept]

Phrase: "SNP D' values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "graphically"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Graphical Overview of LD (GOLD) software package,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0814812:overview [Intellectual Product]

Phrase: "which"

Phrase: "generates"

Phrase: "the color-coded plot of the pairwise disequilibrium statistics"

Phrase: "with horizontal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205126:Horizontal [Spatial Concept]

Phrase: "and"

Phrase: "vertical axes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1704553:Vertical Axis [Spatial Concept]
   827   C0004457:Axis [Body Part, Organ, or Organ Component]
   827   C0999597:Axis [Mammal]
   827   C1522496:Axis [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "scaled according to the"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0680240:according [Social Behavior]
   737   C0175659:Scale [Medical Device]
   737   C0349674:Scale [Intellectual Product]
   737   C1947916:Scale [Activity]
   737   C3536777:Scale [Manufactured Object]

Phrase: "inter-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205103:Inter- [Spatial Concept]
  1000   C1548610:Inter [Temporal Concept]

Phrase: "SNP distances"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0012751:distances [Quantitative Concept]
   777 E C0443203:Distant [Spatial Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: Each six-SNP disequilibrium block was analyzed using HAPLO.SCORE (25) and Dandelion (26). 

Phrase: "Each six-SNP disequilibrium block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0028778:Block [Pathologic Function]
   812   C0332206:Block [Functional Concept]
   812   C1533157:Block [Substance]
   812   C1706084:Block [Geographic Area]
   812   C2828370:Block [Quantitative Concept]
   741 E C2983591:BLOCKED [Research Activity]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HAPLO.SCORE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Score [Quantitative Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "Dandelion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0440015:DANDELION [Organic Chemical,Pharmacologic Substance]
  1000   C0877851:Dandelion [Plant]
  1000   C0939896:dandelion [Pharmacologic Substance]
  1000   C1093500:Dandelion [Plant]
  1000   C1256220:dandelion [Pharmacologic Substance]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.74: Haplotype frequencies were estimated, and association analyses were performed with respect to type 2 diabetes in our case-control population. 

Phrase: "Haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "association analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed with respect to type 2 diabetes"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0011860:Type 2 Diabetes [Disease or Syndrome]
   778   C0441730:Type 2 [Classification]
   774   C1320657:Diabetes type [Finding]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332307:Type [Qualitative Concept]
   748   C0679133:respect [Social Behavior]
   748   C0884358:Performed [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in our case-control population."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0032662:control population [Occupation or Discipline]
   901   C0872128:case control [Health Care Activity]
   827   C0032659:Population [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1257890:Population [Population Group]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.75: Table 2 summarizes the results of HAPLO.SCORE and Dandelion evaluating the six-SNP haplotypes, in which the specific haplotypes are identified, the frequency of each haplotype is estimated in case and control subjects, a score for each haplotype (Hap score) is calculated, and an empirical P value is calculated for the significance of each Hap score. 

Phrase: "Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "summarizes"

Phrase: "the results of HAPLO.SCORE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "Dandelion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0440015:DANDELION [Organic Chemical,Pharmacologic Substance]
  1000   C0877851:Dandelion [Plant]
  1000   C0939896:dandelion [Pharmacologic Substance]
  1000   C1093500:Dandelion [Plant]
  1000   C1256220:dandelion [Pharmacologic Substance]

Phrase: "evaluating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0220825:Evaluate [Functional Concept]

Phrase: "the six-SNP haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "in which"

Phrase: "the specific haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "the frequency of each haplotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "is"

Phrase: "estimated in case"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0750572:Estimated [Quantitative Concept]
   790   C0868928:Case [Functional Concept]
   790   C1706255:CASE [Medical Device]
   790   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control subjects,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "a score for each haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449820:Score [Quantitative Concept]

Phrase: "(Hap score"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Score [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: ","

Phrase: "and"

Phrase: "an empirical P value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "calculated for the significance of each Hap score."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0237881:Significance [Quantitative Concept]
   744   C0444686:Calculated [Functional Concept]
   744   C0449820:Score [Quantitative Concept]
   744   C0750502:Significance [Idea or Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.76: A negative Hap score indicates that the haplotype occurs more frequently in control subjects, whereas a positive Hap score indicates that the haplotype occurs more frequently in type 2 diabetic case subjects. 

Phrase: "A negative Hap score"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449820:Score [Quantitative Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "more frequently in control subjects,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0205172:More [Functional Concept]
   760   C0243148:control [Qualitative Concept]
   760   C0332183:Frequently [Temporal Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "whereas"

Phrase: "a positive Hap score"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449820:Score [Quantitative Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "more frequently in type 2 diabetic case subjects."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0441730:Type 2 [Classification]
   744   C0205172:More [Functional Concept]
   744   C0241863:DIABETIC [Finding]
   744   C0332183:Frequently [Temporal Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0868928:Case [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]
Processing 00000000.tx.77: In addition, a global P value, which reflects the significance of the difference between type 2 diabetic case and control subjects, is reported. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a global P value,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1709380:P-Value [Quantitative Concept]
   827   C1522609:Value [Quantitative Concept]

Phrase: "which"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the significance of the difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "between type 2 diabetic case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0868928:Case [Functional Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control subjects,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "is"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.78: View this table: [in this window] [in a new window]  TABLE 2 Haplotype analysis of six-SNP HNF4A haplotypes in type 2 diabetic ESRD subjects vs. control subjects using HAPLO.SCORE (25) and Dandelion (26)  In the analysis of the six-SNP disequilibrium block (rs2868093, rs4810424, rs1884613, rs1884614, rs2144908,and rs6073418) encompassing the P2 region, the frequencies of haplotypes in case and control subjects were strongly statistically different (overall P = 2 x 106) (Table 2). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 2 Haplotype analysis of six-SNP HNF4A haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0085801:Analysis, Factor [Quantitative Concept]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1524024:analysis [Functional Concept]

Phrase: "in type 2 diabetic ESRD subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
   711   C0457464:type disease [Intellectual Product]

Phrase: "vs. control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HAPLO.SCORE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Score [Quantitative Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "Dandelion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0440015:DANDELION [Organic Chemical,Pharmacologic Substance]
  1000   C0877851:Dandelion [Plant]
  1000   C0939896:dandelion [Pharmacologic Substance]
  1000   C1093500:Dandelion [Plant]
  1000   C1256220:dandelion [Pharmacologic Substance]

Phrase: "(26"

Phrase: ")"

Phrase: "In the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of the six-SNP disequilibrium block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0028778:Block [Pathologic Function]
   812   C0332206:Block [Functional Concept]
   812   C1533157:Block [Substance]
   812   C1706084:Block [Geographic Area]
   812   C2828370:Block [Quantitative Concept]
   741 E C2983591:BLOCKED [Research Activity]

Phrase: "(rs2868093,"

Phrase: "rs4810424,"

Phrase: "rs1884613,"

Phrase: "rs1884614,"

Phrase: "rs2144908,"

Phrase: "and"

Phrase: "rs6073418"

Phrase: ")"

Phrase: "encompassing"

Phrase: "the P2 region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "the frequencies of haplotypes"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   770   C0439603:Frequencies [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "in case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "strongly statistically different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: "(overall P = 2 x 106"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0282416:Overall [Intellectual Product]
   804   C1561607:Overall [Qualitative Concept]

Phrase: ")"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: This highly significant difference was not due to the difference in frequencies between the three common haplotypes that were estimated. 

Phrase: "This highly significant difference"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]
   734   C1299395:Highly significant [Qualitative Concept]

Phrase: "was"

Phrase: "not due to the difference"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C1518422:Not [Functional Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "in frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: "between the three common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "that"

Phrase: "were"

Phrase: "estimated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]
Processing 00000000.tx.80: Two of these haplotypes, TCGTAC and CGCCGT, are more common in the control population. 

Phrase: "Two of these haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205448:Two [Quantitative Concept]

Phrase: "TCGTAC"

Phrase: "and"

Phrase: "CGCCGT,"

Phrase: "are"

Phrase: "more common in the control population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]
Processing 00000000.tx.81: The third haplotype, CGCCGC, is more common in the case population, but these differences are not statistically significant. 

Phrase: "The third haplotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "CGCCGC,"

Phrase: "is"

Phrase: "more common in the case population,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "but"

Phrase: "these differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "not statistically significant."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1273937:Not significant [Finding]
   901   C0237881:statistically significant [Quantitative Concept]
           significant
   829 E C1709380:Statistical Significance [Quantitative Concept]
   827   C0038215:Statistically [Occupation or Discipline]
   827   C0750502:Significant [Idea or Concept]
   827   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.82: The evidence for association with diabetes is due to substantial differences in frequencies in case and control subjects (P < 0.001) for two uncommon haplotypes, TCCTAC (2.4% of case subjects and 0% of control subjects) and CGGCGT (2.2% of case subjects and 0% of control subjects). 

Phrase: "The evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "with diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "is due to substantial differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C3146286:Due [Idea or Concept]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: "in case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "for two uncommon haplotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "TCCTAC"

Phrase: "(2.4% of case subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0740116:+2 [Quantitative Concept]
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "0% of control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "CGGCGT"

Phrase: "(2.2% of case subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0740116:+2 [Quantitative Concept]
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "0% of control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: ")."
Processing 00000000.tx.83: A single SNP, rs1884613, differentiates between the uncommon risk and common, but not risk-associated, haplotypes (TCTAC risk versus TCTAC and CGCGT risk versus CGCGT). 

Phrase: "A single SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]

Phrase: "rs1884613,"

Phrase: "differentiates between the uncommon risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205615:differentiate [Qualitative Concept]
   760   C0522498:Uncommon [Qualitative Concept]

Phrase: "and"

Phrase: "common,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "risk-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "associated, haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "(TCTAC risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "versus"

Phrase: "TCTAC"

Phrase: "and"

Phrase: "CGCGT risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "versus"

Phrase: "CGCGT"

Phrase: ")."
Processing 00000000.tx.84: Because significant risk haplotype associations were observed in the absence of single SNP associations, we investigated whether nearby functional or coding SNPs were contributing to the observed haplotype associations. 

Phrase: "Because"

Phrase: "significant risk haplotype associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0004083:Associations [Mental Process]
   779 E C0439849:Association [Qualitative Concept]
   779 E C0596306:Association [Phenomenon or Process]
   779 E C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "observed in the absence of single SNP associations,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   744   C0004083:Associations [Mental Process]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C0752046:SNP [Nucleotide Sequence]
   744   C1441672:Observed [Functional Concept]
   744   C1527094:SNP [Conceptual Entity]
   744   C1689985:Absence [Anatomical Abnormality]
   711 E C0439849:Association [Qualitative Concept]
   711 E C0596306:Association [Phenomenon or Process]
   711 E C0699792:association [Social Behavior]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "nearby functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205245:Functional [Functional Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]

Phrase: "or"

Phrase: "coding SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "contributing to the observed haplotype associations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880177:Contributing [Activity]
Processing 00000000.tx.85: We sequenced the P2 promoter and alternate exon 1d (774 bp) in all Caucasian type 2 diabetic case subjects having either the TCCTAC (11 heterozygotes and 2 homozygotes) or CGGCGT (14 heterozygotes) risk haplotype. 

Phrase: "We"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "the P2 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "alternate exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "(774 bp) in all Caucasian type 2 diabetic case subjects"

Phrase: "having"

Phrase: "either"

Phrase: "the TCCTAC"

Phrase: "(11 heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019425:Heterozygotes [Organism Attribute]

Phrase: "and"

Phrase: "2 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "CGGCGT"

Phrase: "(14 heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019425:Heterozygotes [Organism Attribute]

Phrase: ")"

Phrase: "risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035647:Risk [Qualitative Concept]

Phrase: "haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.86: In addition, we sequenced an equal number of Caucasian control subjects. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "an equal number of Caucasian control subjects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.87: Our sequence analysis identified no mutations or polymorphisms in the P2/exon 1d region, suggesting that in our type 2 diabetic population there are no polymorphisms in the nearby functional or coding sequences that are in LD with the type 2 diabetes risk haplotype (i.e., there is no obvious sequence difference that may be the true causal variant). 

Phrase: "Our sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "no mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "polymorphisms in the P2/exon 1d region,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that in our type 2 diabetic population there"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441730:Type 2 [Classification]
   744   C0032659:Population [Quantitative Concept]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C1257890:Population [Population Group]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "no polymorphisms in the nearby functional"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "or"

Phrase: "coding sequences"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   966   C0079941:Coding Sequence [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C0805701:Code [Intellectual Product]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "that"

Phrase: "are in LD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with the type 2 diabetes risk haplotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0018591:Haplotype [Organism Attribute]
   717   C0011860:Type 2 Diabetes [Disease or Syndrome]

Phrase: "(i.e., there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "no obvious sequence difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "the true causal variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.88: Because of the unusual observation that a single SNP differentiates between risk and nonrisk haplotypes in this first LD block, we confirmed the genotyping results by sequencing rs1884613 and the surrounding genomic sequence (540 bp) in 96 Caucasian type 2 diabetic case subjects in an effort to confirm the genotypes assigned by the Sequenom method. 

Phrase: "Because of the unusual observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "a single SNP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0752046:SNP [Nucleotide Sequence]
   861   C1527094:SNP [Conceptual Entity]

Phrase: "differentiates between risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035647:Risk [Qualitative Concept]
   790   C0205615:differentiate [Qualitative Concept]

Phrase: "and"

Phrase: "nonrisk haplotypes in this first LD block,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0018591:Haplotypes [Organism Attribute]

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the genotyping results by sequencing rs1884613"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the surrounding genomic sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "(540 bp) in 96 Caucasian type 2 diabetic case"

Phrase: "subjects in an effort to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0015264:Effort [Organism Function]
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "assigned by the Sequenom method."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C1516050:Assigned [Functional Concept]
   760   C1552601:assigned [Intellectual Product]
Processing 00000000.tx.89: Concordance of 100% was observed with the genotypes determined using the Sequenom method (data not shown). 

Phrase: "Concordance of 100%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:concordance [Social Behavior]

Phrase: "was"

Phrase: "observed with the genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017431:Genotypes [Organism Attribute]
   770   C1441672:Observed [Functional Concept]

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Sequenom method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.90: In the analysis of the second six-SNP disequilibrium block (rs1885088, rs1885089, rs3212198, rs1028583, rs1028584, and rs2273618) encompassing the region from intron 3 to intron 7, the haplotype frequencies in case and control subjects were statistically different (overall P < 0.0001) (Table 2). 

Phrase: "In the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of the second six-SNP disequilibrium block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0028778:Block [Pathologic Function]
   804   C0332206:Block [Functional Concept]
   804   C1533157:Block [Substance]
   804   C1706084:Block [Geographic Area]
   804   C2828370:Block [Quantitative Concept]
   733 E C2983591:BLOCKED [Research Activity]

Phrase: "(rs1885088,"

Phrase: "rs1885089,"

Phrase: "rs3212198,"

Phrase: "rs1028583,"

Phrase: "rs1028584,"

Phrase: "and"

Phrase: "rs2273618"

Phrase: ")"

Phrase: "encompassing"

Phrase: "the region from intron 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "to intron 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the haplotype frequencies in case"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "statistically different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "(overall P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0282416:Overall [Intellectual Product]
   812   C1561607:Overall [Qualitative Concept]

Phrase: ")"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: Two of the common haplotypes (GCCTAT and GCTGCC) occur more frequently in the case population, but only the GCCTAT haplotype is marginally significant (P = 0.05) for association with type 2 diabetes, whereas the third common haplotype (ATTGCC) occurs at equal frequencies in the case and control populations. 

Phrase: "Two of the common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: "(GCCTAT"

Phrase: "and"

Phrase: "GCTGCC"

Phrase: ")"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "more frequently in the case population,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0032659:Population [Quantitative Concept]
   753   C0205172:More [Functional Concept]
   753   C0332183:Frequently [Temporal Concept]
   753   C0868928:Case [Functional Concept]
   753   C1257890:Population [Population Group]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the GCCTAT haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "is"

Phrase: "marginally significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(P = 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "for association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "whereas"

Phrase: "the third common haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotype [Organism Attribute]

Phrase: "(ATTGCC"

Phrase: ")"

Phrase: "occurs at equal frequencies"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0205163:Equal [Qualitative Concept]
   770   C0439603:Frequencies [Temporal Concept]
   770   C1549782:Equal [Idea or Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control populations."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C0032662:control population [Occupation or Discipline]
   861   C0032659:Population [Quantitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1257890:Population [Population Group]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.92: Similar to the P2 disequilibrium block, evidence for association in this six-SNP block is due to significant differences in frequencies in case and control subjects for two uncommon haplotypes, GCCGCT (6.80% of control subjects and 0.34% of case subjects) and GCTTAC (5.02% of control subjects and 0% of case subjects), which are significantly more prevalent in the control population than in the case subjects (P < 0.001). 

Phrase: "Similar to the P2 disequilibrium block,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "in this six-SNP block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0028778:Block [Pathologic Function]
   827   C0332206:Block [Functional Concept]
   827   C1533157:Block [Substance]
   827   C1706084:Block [Geographic Area]
   827   C2828370:Block [Quantitative Concept]
   755 E C2983591:BLOCKED [Research Activity]

Phrase: "is due to significant differences"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0439603:Frequencies [Temporal Concept]
   966 E C0376249:frequency [Quantitative Concept]
   966 E C0871396:Frequency [Quantitative Concept]
   966 E C1561548:Frequency [Qualitative Concept]
   966 E C1705502:Frequency [Quantitative Concept]
   916 E C0332183:Frequent [Temporal Concept]

Phrase: "in case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control subjects for two uncommon haplotypes,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "GCCGCT"

Phrase: "(6.80% of control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "0.34% of case subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "GCTTAC"

Phrase: "(5.02% of control subjects"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0243148:control [Qualitative Concept]
   760   C0439084:>5 [Quantitative Concept]
   760   C0728893:+5 [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "0% of case subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "significantly more prevalent in the control population"

Phrase: "than"

Phrase: "in the case subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.93: Recently, a rare loss-of-function mutation in exon 4 of HNF4A has been identified, and this mutation was found to be associated with type 2 diabetes in Japanese subjects (28). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a rare loss-of-function mutation in exon 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of HNF4A"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Japanese subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.94: Because our uncommon protective haplotypes in the second LD block encompass exon 4, we scanned our populations for the T130I mutation by sequencing exon 4 in Caucasian control subjects having either the GCCGCT (19 heterozygotes and 3 homozygotes) or GCTTAC (18 heterozygotes and 7 homozygotes) protective haplotype. 

Phrase: "Because"

Phrase: "our uncommon protective haplotypes in the second LD block"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0018591:Haplotypes [Organism Attribute]

Phrase: "encompass"

Phrase: "exon 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "our populations for the T130I mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]

Phrase: "by sequencing exon 4"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1553778:Sequencing [Intellectual Product]
   827   C1561491:Sequencing [Functional Concept]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162326:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]

Phrase: "in Caucasian control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "having"

Phrase: "either"

Phrase: "the GCCGCT"

Phrase: "(19 heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019425:Heterozygotes [Organism Attribute]

Phrase: "and"

Phrase: "3 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: ")"

Phrase: "or"

Phrase: "GCTTAC"

Phrase: "(18 heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019425:Heterozygotes [Organism Attribute]

Phrase: "and"

Phrase: "7 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: ")"

Phrase: "protective haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.95: In addition, we sequenced an equal number of Caucasian type 2 diabetic case subjects bearing neither of the protective haplotypes. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "an equal number of Caucasian type 2 diabetic case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1882124:Number Type [Conceptual Entity]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "bearing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]

Phrase: "neither of the protective haplotypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018591:Haplotypes [Organism Attribute]
   760   C3274651:Neither [Qualitative Concept]
Processing 00000000.tx.96: Our sequencing data identified no T130I mutations or any other coding mutations in exon 4 (data not shown). 

Phrase: "Our sequencing data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "no T130I mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "any other coding mutations in exon 4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.97: These results are not surprising because the T130I mutation is associated with an increased risk for type 2 diabetes, and therefore it would be surprising to observe this allele in control individuals bearing a protective haplotype.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "surprising"

Phrase: "because"

Phrase: "the T130I mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "associated with an increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "it"

Phrase: "would"

Phrase: "be"

Phrase: "surprising"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "this allele in control individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "a protective haplotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]
Processing 00000000.tx.98: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Recent studies suggest that four SNPs near the P2 promoter of HNF4A are significantly associated with diabetes status and that evidence for linkage at 20q13 could be attributed to the families carrying a risk allele (16,17). 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that four SNPs near the P2 promoter of HNF4A"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   763   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   734   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0032529:polymorphisms [Genetic Function]
   734   C0037179:Single [Population Group]
   734   C0087136:single [Finding]
   734   C0205171:Single [Quantitative Concept]
   701 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "significantly"

Phrase: "associated with diabetes status"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1317301:Diabetes status [Organism Attribute]
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0449438:Status [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "that evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "at 20q13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521061:20q13 [Cell Component]

Phrase: "could"

Phrase: "be"

Phrase: "attributed to the families"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0015576:Families [Family Group]
   770   C1704727:Family [Conceptual Entity]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a risk allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.99: Independently, we evaluated 23 SNPs spanning 111.23 kb of the HNF4A gene region in a case-control association study. 

Phrase: "Independently,"

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "23 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "111.23 kb of the HNF4A gene region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   754   C0387852:KB 23 [Organic Chemical,Pharmacologic Substance]

Phrase: "in a case-control association study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0007328:Case-Control Study [Research Activity]
   902   C0085973:Case Study [Intellectual Product]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.100: Included in this analysis were the four SNPs in the P2 promoter region found to be associated in both Finnish and Ashkenazi samples (rs4810424, rs1884613, rs1884614, and rs2144908), three SNPs found to be associated in Finnish samples only (rs2425637, rs2425640, and rs1885088), and two SNPs found to be associated in Ashkenazi samples only (rs1028583 and rs3818247). 

Phrase: "Included in this analysis"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0332257:included [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "were"

Phrase: "the four SNPs in the P2 promoter region"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   782   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   739   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0032529:polymorphisms [Genetic Function]
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0205171:Single [Quantitative Concept]
   706 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated in both Finnish"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0332281:Associated [Qualitative Concept]
   770   C1711254:Finnish [Population Group]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "Ashkenazi samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(rs4810424,"

Phrase: "rs1884613,"

Phrase: "rs1884614,"

Phrase: "and"

Phrase: "rs2144908"

Phrase: ")"

Phrase: ","

Phrase: "three SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated in Finnish samples only"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0205171:Only [Quantitative Concept]
   760   C0332281:Associated [Qualitative Concept]
   760   C1711254:Finnish [Population Group]
   760   C1720467:Only [Intellectual Product]
   726   C0370003:Sample [Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "(rs2425637,"

Phrase: "rs2425640,"

Phrase: "and"

Phrase: "rs1885088"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "two SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated in Ashkenazi samples only"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205171:Only [Quantitative Concept]
   760   C0332281:Associated [Qualitative Concept]
   760   C1720467:Only [Intellectual Product]
   726   C0370003:Sample [Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "(rs1028583"

Phrase: "and"

Phrase: "rs3818247"

Phrase: ")."
Processing 00000000.tx.101: In contrast to the results of Love-Gregory et al. 

Phrase: "In contrast to the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "of Love-Gregory et al."
Processing 00000000.tx.102: (17) and Silander et al. 

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "Silander et al."
Processing 00000000.tx.103: (16), we observed little or no evidence of association with single SNPs (Table 1). 

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with single SNPs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: Our LD and haplotype structure indicate that there are two distinct disequilibrium blocks separated by recombination within this gene region that are each defined by six SNPs. 

Phrase: "Our LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "and"

Phrase: "haplotype structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "indicate"

Phrase: "that there"

Phrase: "are"

Phrase: "two distinct disequilibrium blocks"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0028778:blocks [Pathologic Function]
   812   C0332206:Blocks [Functional Concept]
   812   C1533157:Blocks [Substance]
   779 E C1706084:Block [Geographic Area]
   779 E C2828370:Block [Quantitative Concept]
   729 E C2983591:BLOCKED [Research Activity]

Phrase: "separated by recombination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034865:Recombination [Genetic Function]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "within this gene region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "each"

Phrase: "defined by six SNPs."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0032529:polymorphisms [Genetic Function]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0205452:Six [Quantitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]
   719 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.105: This LD structure broadly corresponds to that reported by Love-Gregory et al. 

Phrase: "This LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "broadly"

Phrase: "corresponds to that"

Phrase: "reported by Love-Gregory et al."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1709908:Reported By [Group]
   753   C0024028:Love [Mental Process]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.106: (17). 

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.107: We used this LD structure to guide the haplotype analysis. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this LD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "guide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0181090:Guide [Professional or Occupational Group]
  1000   C0302614:Guide [Medical Device]
  1000   C1706050:Guide [Manufactured Object]

Phrase: "the haplotype analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.108: Our analysis indicates that in the LD block encompassing the P2 promoter region (Table 2), there are two rare, completely mismatching haplotypes (TCCTAC and CGGCGT) that are significantly associated with type 2 diabetes risk. 

Phrase: "Our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "indicates"

Phrase: "that in the LD block"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0028778:Block [Pathologic Function]
   753   C0281825:Disequilibrium [Finding]
   753   C0332206:Block [Functional Concept]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C1533157:Block [Substance]
   753   C1706084:Block [Geographic Area]
   753   C2828370:Block [Quantitative Concept]

Phrase: "encompassing"

Phrase: "the P2 promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "are"

Phrase: "two rare, completely mismatching haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0018591:Haplotypes [Organism Attribute]

Phrase: "(TCCTAC"

Phrase: "and"

Phrase: "CGGCGT"

Phrase: ")"

Phrase: "that"

Phrase: "are"

Phrase: "significantly"

Phrase: "associated with type 2 diabetes risk."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0011860:Type 2 Diabetes [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0441730:Type 2 [Classification]
   790   C1171304:diabetes risk [Quantitative Concept]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0035647:Risk [Qualitative Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.109: These risk-associated haplotypes differ from the more common, nonrisk haplotypes at a single SNP locus, rs1884613. 

Phrase: "These risk-associated haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "differ from the more common, nonrisk haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0205214:Common [Quantitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C3245511:common [Intellectual Product]

Phrase: "at a single SNP locus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "rs1884613."
Processing 00000000.tx.110: However, rs1884613 showed no trend toward association in our single SNP analysis. 

Phrase: "However,"

Phrase: "rs1884613"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no trend toward association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521798:trend [Temporal Concept]

Phrase: "in our single SNP analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.111: Direct sequencing confirmed that the individual genotypes assigned at this particular locus were correct, indicating that the rare risk haplotypes were not estimated due to genotyping error. 

Phrase: "Direct sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the individual genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "assigned at this particular locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1516050:Assigned [Functional Concept]
   760   C1552601:assigned [Intellectual Product]
   760   C1708726:Locus [Gene or Genome]

Phrase: "were"

Phrase: "correct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the rare risk haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "estimated due to genotyping error."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0743559:error [Qualitative Concept]
   760   C0750572:Estimated [Quantitative Concept]
   760   C1285573:Genotyping [Laboratory Procedure]
   760   C1608199:Error [Functional Concept]
   760   C3146286:Due [Idea or Concept]
   726 E C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.112: In addition to genotyping error, an alternative possibility is that the haplotype-estimating programs (HAPLO.SCORE and Dandelion) do not correctly assign haplotypes in this circumstance of unusual, uncommon haplotypes. 

Phrase: "In addition to genotyping error,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0743559:error [Qualitative Concept]
   861   C1608199:Error [Functional Concept]

Phrase: "an alternative possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the haplotype-estimating programs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0376691:Programs [Intellectual Product]
   827   C3484370:Programs [Functional Concept]
   793 E C1709697:Program [Conceptual Entity]
   793 E C2728259:Program [Pharmacologic Substance]

Phrase: "(HAPLO.SCORE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Score [Quantitative Concept]

Phrase: "and"

Phrase: "Dandelion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0440015:DANDELION [Organic Chemical,Pharmacologic Substance]
  1000   C0877851:Dandelion [Plant]
  1000   C0939896:dandelion [Pharmacologic Substance]
  1000   C1093500:Dandelion [Plant]
  1000   C1256220:dandelion [Pharmacologic Substance]

Phrase: ")"

Phrase: "do"

Phrase: "not correctly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "assign"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516050:Assign [Functional Concept]

Phrase: "haplotypes in this circumstance of unusual, uncommon haplotypes."
Processing 00000000.tx.113: Extensive exploration of this possibility has led us to conclude that haplotype assignments are correct (data not shown). 

Phrase: "Extensive exploration of this possibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1280903:Exploration [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that haplotype assignments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516050:Assignment [Functional Concept]

Phrase: "are"

Phrase: "correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.114: A summary of the haplotype assignments for each individual with the uncommon risk or uncommon protective haplotypes is shown in supplemental Table 1 (available at http://diabetes.diabetesjournals.org). 

Phrase: "A summary of the haplotype assignments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552616:summary [Intellectual Product]
   753   C1706244:Summary [Intellectual Product]

Phrase: "for each individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "with the uncommon risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risk [Qualitative Concept]

Phrase: "or"

Phrase: "uncommon protective haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "is"

Phrase: "shown in supplemental Table 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0039224:Table [Manufactured Object]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   760   C2348609:Supplemental [Functional Concept]
   726   C1547282:Show [Intellectual Product]

Phrase: "(available at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ":"

Phrase: "//diabetes.diabetesjournals.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.115: It is noteworthy that the probability assigned to each haplotype call is >70% for all haplotypes and that the average probability of correct assignment is 88% for the P2 haplotypes and 98% for the intron 3 to intron 7 haplotypes. 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "the probability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0033204:Probability [Quantitative Concept]
   928 E C0332148:Probable [Qualitative Concept]

Phrase: "assigned to each haplotype call is >70%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0018591:Haplotype [Organism Attribute]
   748   C0679006:Call [Mental Process]
   748   C1292769:c-ALL [Neoplastic Process]
   748   C1516050:Assigned [Functional Concept]
   748   C1552601:assigned [Intellectual Product]
   748   C1947967:Call [Functional Concept]

Phrase: "for all haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "that"

Phrase: "the average probability of correct assignment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033204:Probability [Quantitative Concept]

Phrase: "is"

Phrase: "88% for the P2 haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018591:Haplotypes [Organism Attribute]
   760   C1384585:P2 [Immunologic Factor]
   760   C1419693:P2 [Gene or Genome]
   760   C1539372:p2 [Gene or Genome]

Phrase: "and"

Phrase: "98% for the intron 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to intron 7 haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.116: In addition, we have observed that haplotype-specific P values for uncommon haplotypes may not be robustly estimated using HAPLO.SCORE (D. Schaid, personal communication), and the reported Hap scores may better reflect the contributions of specific haplotypes to overall differences between case and control subjects. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that haplotype-specific P values for uncommon haplotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0042295:Values [Qualitative Concept]
   737   C1709380:P-Value [Quantitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "robustly"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HAPLO.SCORE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Score [Quantitative Concept]

Phrase: "(D. Schaid,"

Phrase: "personal communication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the reported Hap scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449820:Scores [Quantitative Concept]

Phrase: "may"

Phrase: "better"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the contributions of specific haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1880177:Contribution [Activity]

Phrase: "to overall differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "between case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "control subjects."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.117: Focusing on the Hap scores alone does not alter our interpretation of the haplotype analysis. 

Phrase: "Focusing on the Hap"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0000936:focusing [Clinical Attribute]
   770   C2981153:Focusing [Finding]
   737 E C0205234:Focus [Spatial Concept]
   737 E C1285542:focus [Functional Concept]

Phrase: "scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:Score [Quantitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "our interpretation of the haplotype analysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0459471:Interpretation [Intellectual Product]
   753   C3173575:Interpretation [Clinical Attribute]
Processing 00000000.tx.118: Alternate exon 1d and the P2 promoter region were sequenced in all individuals carrying either of these risk haplotypes. 

Phrase: "Alternate exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "and"

Phrase: "the P2 promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "sequenced in all individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   737   C0004793:Sequence [Nucleotide Sequence]
   737   C0027361:Individual [Population Group]
   737   C0162326:Sequence [Nucleotide Sequence]
   737   C0162327:Sequence [Nucleotide Sequence]
   737   C0237401:Individual [Human]
   737   C1519249:Sequence [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "either of these risk haplotypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018591:Haplotypes [Organism Attribute]
   760   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.119: No mutations or polymorphisms were identified, which suggests that the observed associations are not driven by nearby functional or coding mutations. 

Phrase: "No mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the observed associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "driven by nearby functional"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205245:Functional [Functional Concept]
   770   C0542341:Functional [Functional Concept]
   770   C2700217:Functional [Conceptual Entity]
   737   C0013126:Drive [Mental Process]

Phrase: "or"

Phrase: "coding mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.120: Because the two risk haplotypes are completely mismatching and because they differ from the common nonrisk haplotypes at a single locus that is not individually associated with an increased risk, we hypothesize that unique combinations of SNP alleles may be driving the observed associations and that the phenotype is due to multiple variants working in combination. 

Phrase: "Because"

Phrase: "the two risk haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "completely mismatching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881865:Mismatch [Qualitative Concept]

Phrase: "and"

Phrase: "because"

Phrase: "they"

Phrase: "differ from the common nonrisk haplotypes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0018591:Haplotypes [Organism Attribute]
   753   C0205214:Common [Quantitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C3245511:common [Intellectual Product]

Phrase: "at a single locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "not individually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "associated with an increased risk,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that unique combinations of SNP alleles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0453882:Combinations [Manufactured Object]
   719 E C0205195:Combination [Qualitative Concept]
   719 E C1947911:Combination [Physical Object]

Phrase: "may"

Phrase: "be"

Phrase: "driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004379:Driving [Daily or Recreational Activity]
   966 E C0013126:Drive [Mental Process]

Phrase: "the observed associations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0004083:Associations [Mental Process]
   827 E C0439849:Association [Qualitative Concept]
   827 E C0596306:Association [Phenomenon or Process]
   827 E C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "that"

Phrase: "the phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is due to multiple variants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0205419:variants [Qualitative Concept]
   760   C0439064:Multiple [Quantitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "working in combination."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043227:Working [Occupational Activity]
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]
Processing 00000000.tx.121: In the LD block covering the genomic region from intron 3 to intron 7 (Table 2), there are two rare haplotypes (GCTTAC and GCCGCT) that are significantly associated with a decreased risk for type 2 diabetes and a single common risk haplotype GCCTAT that is marginally significant for type 2 diabetes risk (P = 0.05). 

Phrase: "In the LD block"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0028778:Block [Pathologic Function]
   827   C0332206:Block [Functional Concept]
   827   C1533157:Block [Substance]
   827   C1706084:Block [Geographic Area]
   827   C2828370:Block [Quantitative Concept]
   755 E C2983591:BLOCKED [Research Activity]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "the genomic region from intron 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017428:Genomic [Gene or Genome]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "to intron 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "are"

Phrase: "two rare haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "(GCTTAC"

Phrase: "and"

Phrase: "GCCGCT"

Phrase: ")"

Phrase: "that"

Phrase: "are"

Phrase: "significantly"

Phrase: "associated with a decreased risk"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035647:Risk [Qualitative Concept]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "a single common risk haplotype GCCTAT"

Phrase: "that"

Phrase: "is"

Phrase: "marginally significant for type 2 diabetes risk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237881:significant [Quantitative Concept]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]

Phrase: "(P = 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.122: Because the T130I loss-of-function mutation in exon 4 was recently identified (28), we sequenced exon 4 in all individuals carrying either of these protective haplotypes. 

Phrase: "Because"

Phrase: "the T130I loss-of-function mutation in exon 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "exon 4 in all individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "either of these protective haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.123: The mutation was not present in any of the control samples bearing the protective haplotypes. 

Phrase: "The mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in any of the control samples"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0150312:Present [Quantitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0449450:Present [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the protective haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.124: Because no nearby coding mutations have been identified that can account for these haplotypic associations, a combination of SNPs may be required to confer protection. 

Phrase: "Because"

Phrase: "no nearby coding mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "that"

Phrase: "can"

Phrase: "account for these haplotypic associations,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0004083:Associations [Mental Process]
   760   C1551359:account [Idea or Concept]
   760   C2741673:Account # [Clinical Attribute]
   760   C2981730:Account [Classification]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "a combination of SNPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]
Processing 00000000.tx.125: Baroso et al. 

Phrase: "Baroso et al."
Processing 00000000.tx.126: (27) recently suggested the possibility of protective haplotypes in the coding region of HNF4A; 

Phrase: "(27"

Phrase: ")"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility of protective haplotypes"

Phrase: "in the coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of HNF4A"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   923   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0227525:Hepatocyte [Cell]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.127: however, SNPs comprising such protective haplotypes were not genotyped in this study. 

Phrase: "however,"

Phrase: "SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "comprising"

Phrase: "such protective haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "genotyped in this study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.128: Whereas we used the LD structure of the gene region to guide our haplotype analysis, Silander et al. 

Phrase: "Whereas"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the LD structure of the gene region to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1517495:Gene Structure [Gene or Genome]
   742   C0678594:Structure [Spatial Concept]
   726 E C0017366:Structural gene [Gene or Genome]

Phrase: "guide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0181090:Guide [Professional or Occupational Group]
  1000   C0302614:Guide [Medical Device]
  1000   C1706050:Guide [Manufactured Object]

Phrase: "our haplotype analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "Silander et al."
Processing 00000000.tx.129: (16) estimated haplotype frequencies using six SNPs spanning two distinct LD blocks and regions of recombination between blocks. 

Phrase: "(16"

Phrase: ")"

Phrase: "estimated haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "six SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "two distinct LD blocks"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0028778:blocks [Pathologic Function]
   804   C0332206:Blocks [Functional Concept]
   804   C1533157:Blocks [Substance]
   771 E C1706084:Block [Geographic Area]
   771 E C2828370:Block [Quantitative Concept]
   721 E C2983591:BLOCKED [Research Activity]

Phrase: "and"

Phrase: "regions of recombination"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   756   C0017446:Region [Geographic Area]
   756   C0205147:Region [Spatial Concept]
   706 E C0205276:Regional [Spatial Concept]
   706 E C1947913:Regional [Spatial Concept]

Phrase: "between blocks."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:blocks [Pathologic Function]
  1000   C0332206:Blocks [Functional Concept]
  1000   C1533157:Blocks [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]
   916 E C2983591:BLOCKED [Research Activity]
Processing 00000000.tx.130: Because our analysis included four of these six SNPs (rs2144908, rs2425637, rs2425640, and rs1885088), we estimated haplotypes using these four SNPs. 

Phrase: "Because"

Phrase: "our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "four of these six SNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   814   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0032529:polymorphisms [Genetic Function]
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0205171:Single [Quantitative Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C0205452:Six [Quantitative Concept]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(rs2144908,"

Phrase: "rs2425637,"

Phrase: "rs2425640,"

Phrase: "and"

Phrase: "rs1885088"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these four SNPs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.131: Although our analysis identified the same haplotypes as those reported by Silander et al. 

Phrase: "Although"

Phrase: "our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the same haplotypes as those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0018591:Haplotypes [Organism Attribute]

Phrase: "reported by Silander et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.132: (16), none of the haplotypes were significantly associated (P values ranging from 0.16 to 0.99; overall empirical P = 0.73) (data not shown). 

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "none of the haplotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018591:Haplotypes [Organism Attribute]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "ranging from 0.16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 0.99"

Phrase: "; overall empirical P = 0.73"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0282416:Overall [Intellectual Product]
   804   C1561607:Overall [Qualitative Concept]
   804   C1880496:Empirical [Qualitative Concept]

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: HNF4A SNPs do not seem to play the major role in type 2 diabetes susceptibility in our study population that has been observed in studies of Finnish (16) and Ashkenazi Jewish (17) families. 

Phrase: "HNF4A SNPs"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   845   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   795   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0032529:polymorphisms [Genetic Function]
   795   C0037179:Single [Population Group]
   795   C0087136:single [Finding]
   795   C0205171:Single [Quantitative Concept]
   762 E C1882417:Polymorphism [Qualitative Concept]
   710   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "the major role in type 2 diabetes susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in our study population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2348561:Study Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C0557651:Study [Manufactured Object]
   861   C1257890:Population [Population Group]
   861   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "observed in studies of Finnish"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0947630:studies [Laboratory Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C1711254:Finnish [Population Group]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "Ashkenazi Jewish"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022422:Jewish [Idea or Concept]
   861   C0178443:Jewish [Population Group]

Phrase: "(17"

Phrase: ")"

Phrase: "families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.134: It is interesting to note that we observed stronger evidence for association to type 2 diabetes susceptibility with the nearby PTPN1 gene on 20q13 (29,30). 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "stronger evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "to type 2 diabetes susceptibility"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0012655:Susceptibility [Clinical Attribute]
   812   C0220898:Susceptibility [Organism Attribute]
   812   C1264642:Susceptibility [Functional Concept]
   812   C1547045:*Susceptibility [Quantitative Concept]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   741 E C0231204:Susceptible [Functional Concept]
   741 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
   708   C1320657:type diabetes [Finding]

Phrase: "with the nearby PTPN1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1335281:PTPN1 gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "on 20q13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521061:20q13 [Cell Component]

Phrase: "(29,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.135: The results of HNF4A haplotype analysis suggest, however, that there is some type 2 diabetes risk associated with HNF4A in our population. 

Phrase: "The results of HNF4A haplotype analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: ","

Phrase: "however,"

Phrase: "that there"

Phrase: "is"

Phrase: "some type 2 diabetes risk"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1171304:diabetes risk [Quantitative Concept]
   812   C0035647:Risk [Qualitative Concept]
   756   C0011860:Type 2 Diabetes [Disease or Syndrome]
   708   C1320657:type diabetes [Finding]

Phrase: "associated with HNF4A"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   833   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0227525:Hepatocyte [Cell]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in our population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.136: It should be informative to test these haplotype effects in other populations. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "informative to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986490:Informative [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "these haplotype effects in other populations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.137: The risk haplotypes in the P2 region were only observed in case subjects, suggesting that they may have a substantial impact on HNF4A gene expression or message stability. 

Phrase: "The risk haplotypes in the P2 region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0018591:Haplotypes [Organism Attribute]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in case subjects,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0868928:Case [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "may"

Phrase: "have"

Phrase: "a substantial impact on HNF4A gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1825598:IMPACT gene [Gene or Genome]
           IMPACT

Phrase: "or"

Phrase: "message stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.138: Similar conclusions can be drawn about the HNF4A protective haplotypes. 

Phrase: "Similar conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusions [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "drawn about the HNF4A protective haplotypes."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   790   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0679688:Protective Factor [Biologic Function]
   742   C0018591:Haplotypes [Organism Attribute]
   742   C0227525:Hepatocyte [Cell]
   742   C0521447:Nuclear [Spatial Concept]
   742   C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   708   C0013113:Draw [Intellectual Product]
Processing 00000000.tx.139: It should be noted that failure to replicate the evidence reported by Silander et al. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "replicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "reported by Silander et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.140: (16) and Love-Gregory et al. 

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "Love-Gregory et al."
Processing 00000000.tx.141: (17) could be due to lack of statistical power. 

Phrase: "(17"

Phrase: ")"

Phrase: "could"

Phrase: "be due to lack of statistical power."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0678226:Due to [Functional Concept]
           due
   778   C0814897:Statistical Power [Research Activity]
   748   C0032863:Power [Human-caused Phenomenon or Process]
   748   C0038215:Statistical [Occupation or Discipline]
   748   C0332268:lack [Qualitative Concept]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]
Processing 00000000.tx.142: Our case-control population has 80% power to detect P 0.05 for an odds ratio of 1.5. 

Phrase: "Our case-control population"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0032662:control population [Occupation or Discipline]
   901   C0872128:case control [Health Care Activity]
   827   C0032659:Population [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1257890:Population [Population Group]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "has"

Phrase: "80% power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "P 0.05 for an odds ratio of 1.5."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0028873:Odds Ratio [Quantitative Concept]
   757   C0444499:0/5 [Quantitative Concept]
   739   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0456603:Ratio [Quantitative Concept]
   739   C1547037:Ratio [Intellectual Product]
   739   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.143: If the true odds ratio for HNF4A is lower, this study may not have the power to detect a significant association. 

Phrase: "If"

Phrase: "the true odds ratio for HNF4A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0028873:Odds Ratio [Quantitative Concept]
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: "is"

Phrase: "lower,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "the power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a significant association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]
Processing 00000000.tx.144: In addition, as noted above, the study population described here consists of case subjects ascertained as unrelated Caucasian Americans with a diagnosis of type 2 diabetes with associated ESRD. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "as"

Phrase: "noted above,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1316572:Note [Clinical Attribute]
   799   C1317574:Note [Intellectual Product]
   799   C1369612:Note [Clinical Attribute]

Phrase: "the study population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2348561:Study Population [Population Group]
   861   C0032659:Population [Quantitative Concept]
   861   C0557651:Study [Manufactured Object]
   861   C1257890:Population [Population Group]
   861   C2603343:Study [Research Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "consists of case subjects"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0332529:CONSIST [Qualitative Concept]
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "ascertained as unrelated Caucasian Americans"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0221786:Caucasian American [Population Group]
   760   C0007457:Caucasian [Population Group]
   760   C0043157:Caucasian [Population Group]
   760   C0445356:Unrelated [Finding]
   760   C0596070:americans [Population Group]
   760   C1704623:Unrelated [Qualitative Concept]

Phrase: "with a diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "with associated ESRD."
Meta Candidates (Total=20; Excluded=6; Pruned=0; Remaining=14)
   937   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
   937   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   897   C0243083:associated disease [Pathologic Function]
   888   C0679247:end stage disease [Disease or Syndrome]
           Terminal Disease
   840   C0022658:Renal disease [Disease or Syndrome]
   840   C0205088:End-stage [Temporal Concept]
       E   Terminal
   804   C0012634:Disease [Disease or Syndrome]
   804   C0022646:Renal [Body Part, Organ, or Organ Component]
   804   C0205390:Stage [Temporal Concept]
   804   C0444930:End [Spatial Concept]
   804   C1300072:Stage [Clinical Attribute]
   804   C1306673:Stage [Qualitative Concept]
   804   C2746065:End [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.145: The populations studied by Silander et al. 

Phrase: "The populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "studied by Silander et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]
Processing 00000000.tx.146: (16) (Finnish type 2 diabetic families) and Love-Gregory et al. 

Phrase: "(16"

Phrase: ")"

Phrase: "(Finnish type 2 diabetic families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Love-Gregory et al."
Processing 00000000.tx.147: (17) (type 2 diabetic families of Ashkenazi Jewish heritage) were ascertained in a different manner. 

Phrase: "(17"

Phrase: ")"

Phrase: "(type 2 diabetic families of Ashkenazi Jewish heritage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Families [Family Group]
   744   C1704727:Family [Conceptual Entity]

Phrase: ")"

Phrase: "were"

Phrase: "ascertained in a different manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.148: Although it seems unlikely, there is the possibility that the HNF4A risk alleles observed by Silander et al. 

Phrase: "Although"

Phrase: "it"

Phrase: "seems"

Phrase: "unlikely, there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "is"

Phrase: "the possibility"

Phrase: "that"

Phrase: "the HNF4A risk alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0002085:Alleles [Gene or Genome]
   734   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]

Phrase: "observed by Silander et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1441672:Observed [Functional Concept]
Processing 00000000.tx.149: (16) and Love-Gregory et al. 

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "Love-Gregory et al."
Processing 00000000.tx.150: (17) confer protection from ESRD and would be rare in the ESRD population. 

Phrase: "(17"

Phrase: ")"

Phrase: "confer"

Phrase: "protection from ESRD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1545588:Protection [Finding]
   716   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
   716   C2316810:End-stage renal disease [Disease or Syndrome,Finding]

Phrase: "and"

Phrase: "would"

Phrase: "be"

Phrase: "rare in the ESRD population."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0678236:Rare Disease [Disease or Syndrome]
   744   C0521114:Rare [Temporal Concept]
   744   C0522498:Rare [Qualitative Concept]
   744   C1514917:RARE [Gene or Genome]
Processing 00000000.tx.151: Comparison of allele frequencies (data not shown) does not directly suggest this. 

Phrase: "Comparison of allele frequencies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "does"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "this."
Processing 00000000.tx.152: Overall, the results reported here, in combination with our analysis of PTPN1, and the results of Silander et al. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here,"

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of PTPN1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335056:PTPN1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1335281:PTPN1 [Gene or Genome]

Phrase: "and"

Phrase: "the results of Silander et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.153: (16) and Love-Gregory et al. 

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "Love-Gregory et al."
Processing 00000000.tx.154: (17) are consistent with a model in which multiple genes on 20q1213 contribute to type 2 diabetes, and different genes affect risk to various degrees in different populations.  

Phrase: "(17"

Phrase: ")"

Phrase: "are"

Phrase: "consistent with a model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in which multiple genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "on 20q1213"

Phrase: "contribute to type 2 diabetes,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   760   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "different genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "risk to various degrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "in different populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.155: ACKNOWLEDGMENTS  D.W.B. has received support from National Institutes of Health Grants R01-DK-56289 and R01-DK-53591.  

Phrase: "ACKNOWLEDGMENTS  D.W.B."

Phrase: "has"

Phrase: "received support from National Institutes of Health Grants R01-DK-56289"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0183683:Support [Medical Device]
   738   C1521721:Support [Conceptual Entity]

Phrase: "and"

Phrase: "R01-DK-53591."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011318:DK [Geographic Area]
   827   C1549838:R01 [Intellectual Product]
Processing 00000000.tx.156: FOOTNOTES  Additional information for this article can be found in an online appendix at http://diabetes.diabetesjournals.org. 

Phrase: "FOOTNOTES  Additional information for this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1546922:Additional information [Temporal Concept]
   790   C1706499:ADDITIONAL INFORMATION [Intellectual Product]
   753   C1533716:Information [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "found in an online appendix"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003617:Appendix [Body Part, Organ, or Organ Component]
   760   C0150312:Found [Quantitative Concept]
   760   C1269000:Appendix [Body Part, Organ, or Organ Component]
   726 E C0243095:Find [Finding]

Phrase: "at http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//diabetes.diabetesjournals.org."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]
Processing 00000000.tx.157: Address correspondence and reprint requests to Donald W. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Donald W."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]
Processing 00000000.tx.158: Bowden, Department of Biochemistry, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157. 

Phrase: "Bowden,"

Phrase: "Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Wake Forest University School of Medicine,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0013227:Medicine, NOS [Pharmacologic Substance]
   799   C0025118:Medicine [Biomedical Occupation or Discipline]
   799   C0036375:School [Manufactured Object,Organization]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0086312:Forest [Geographic Area]
   799   C0442696:wake [Physiologic Function]
   799   C0585034:WAKE [Temporal Concept]

Phrase: "Medical Center Blvd.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   734   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Winston-Salem,"

Phrase: "NC 27157."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027964:NC [Geographic Area]
   861   C0028407:NC [Geographic Area]
   861   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.159: E-mail: dbowden{at}wfubmc.edu Received for publication June 15, 2004 and accepted in revised form November 22, 2004 ESRD, end-stage renal disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "dbowden{at}wfubmc.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication June 15,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004"

Phrase: "and"

Phrase: "accepted in revised form November 22,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2004 ESRD,"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
   937   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
   937   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   888   C0679247:end stage disease [Disease or Syndrome]
           Terminal Disease
   840   C0022658:Renal disease [Disease or Syndrome]
   840   C0205088:End-stage [Temporal Concept]
       E   Terminal
   804   C0012634:Disease [Disease or Syndrome]
   804   C0022646:Renal [Body Part, Organ, or Organ Component]
   804   C0205390:Stage [Temporal Concept]
   804   C0444930:End [Spatial Concept]
   804   C1300072:Stage [Clinical Attribute]
   804   C1306673:Stage [Qualitative Concept]
   804   C2746065:End [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]

Phrase: "end-stage renal disease"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
  1000   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
  1000   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   923   C0679247:end stage disease [Disease or Syndrome]
           Terminal Disease
   861   C0022658:Renal disease [Disease or Syndrome]
   861   C0205088:End-stage [Temporal Concept]
       E   Terminal
   812   C0012634:Disease [Disease or Syndrome]
   812   C0022646:Renal [Body Part, Organ, or Organ Component]
   812   C0205390:Stage [Temporal Concept]
   812   C0444930:End [Spatial Concept]
   812   C1300072:Stage [Clinical Attribute]
   812   C1306673:Stage [Qualitative Concept]
   812   C2746065:End [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.160: HNF, hepatocyte nuclear factor; 

Phrase: "HNF,"

Phrase: "hepatocyte nuclear factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0521447:Nuclear [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.161: LD, linkage disequilibrium; 

Phrase: "LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.162: SNP, single nucleotide polymorphism  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB, Akots G, Rich SS, Freedman BI: Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. 

Phrase: "SNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752046:SNP [Nucleotide Sequence]
  1000   C1527094:SNP [Conceptual Entity]

Phrase: "single nucleotide polymorphism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Bowden DW,"

Phrase: "Sale M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Howard TD,"

Phrase: "Qadri A,"

Phrase: "Spray BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Rothschild CB,"

Phrase: "Akots G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rich SS,"

Phrase: "Freedman BI"

Phrase: ":"

Phrase: "Linkage of genetic markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0023745:genetic linkage [Molecular Function]
           linkage

Phrase: "on human chromosomes 20"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0008643:Chromosomes, Human [Cell Component]
   884   C0008663:Chromosome 20 [Cell Component]
   827   C0008633:Chromosomes [Cell Component]
   827   C0086418:Human [Human]

Phrase: "and"

Phrase: "12 to NIDDM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011860:NIDDM [Disease or Syndrome]
   790   C3273872:NIDDM [Gene or Genome]

Phrase: "in Caucasian sib pairs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037047:Sib [Family Group]
   827   C1709450:Pair [Qualitative Concept]

Phrase: "with a history"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0019664:History [Occupation or Discipline]
  1000   C0019665:history [Intellectual Product]
  1000   C0262512:History, NOS [Organism Attribute]
  1000   C0262926:History [Finding]
  1000   C1705255:History [Conceptual Entity]
  1000   C2004062:History [Finding]
   928 E C1552658:Historical [Idea or Concept]
   928 E C1552723:Historical [Idea or Concept]

Phrase: "of diabetic nephropathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011881:Diabetic Nephropathy [Disease or Syndrome]
  1000   C1442864:diabetic nephropathy [Gene or Genome]
   861   C0022658:Nephropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.163: Diabetes46 :882 886,1997[Abstract] Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS: New susceptibility locus for NIDDM is localized to human chromosome 20q. 

Phrase: "Diabetes46"

Phrase: ":"

Phrase: "882 886,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ji L,"

Phrase: "Malecki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Warram JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y,"

Phrase: "Rich SS,"

Phrase: "Krolewski"

Phrase: "AS"

Phrase: ":"

Phrase: "New susceptibility locus for NIDDM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "is"

Phrase: "localized to human chromosome 20q."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0008643:Human Chromosome [Cell Component]
   797   C2599609:20q chromosome [Cell or Molecular Dysfunction]
   760   C0008633:Chromosome [Cell Component]
   760   C0086418:Human [Human]
   760   C0392752:Localized [Spatial Concept]
   760   C1521048:20q [Nucleotide Sequence]
Processing 00000000.tx.164: Diabetes46 :876 881,1997[Abstract] Zouali H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F, Froguel P: A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. 

Phrase: "Diabetes46"

Phrase: ":"

Phrase: "876 881,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zouali H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hani EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Philippi A,"

Phrase: "Vionnet N,"

Phrase: "Beckmann JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Demenais F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Froguel P"

Phrase: ":"

Phrase: "A susceptibility locus for early-onset non-insulin dependent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1708726:Locus [Gene or Genome]

Phrase: "(type 2) diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "maps to chromosome 20q,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0814036:chromosome map [Intellectual Product]
   819   C2599609:20q chromosome [Cell or Molecular Dysfunction]
   770   C0008633:Chromosome [Cell Component]
   770   C0024779:Map [Manufactured Object]
   770   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1521048:20q [Nucleotide Sequence]
   770   C1706473:Map [Conceptual Entity]

Phrase: "proximal to the phosphoenolpyruvate carboxykinase gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205107:Proximal [Spatial Concept]
Processing 00000000.tx.165: Hum Mol Genet6 :1401 1408,1997[Abstract/Free FullText] Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, Erdos MR, Langefeld CD, Balow J Jr, Ally DS, Kohtamaki K, Chines P, Birznieks G, Kaleta HS, Musick A, Te C, Tannenbaum J, Eldridge W, Shapiro S, Martin C, Witt A, So A, Chang J, Shurtleff B, Porter R, Boehnke M, et al.: 

Phrase: "Hum Mol Genet6"

Phrase: ":"

Phrase: "1401 1408,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ghosh S,"

Phrase: "Watanabe RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Hauser ER,"

Phrase: "Valle T,"

Phrase: "Magnuson VL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0228339:VL [Body Part, Organ, or Organ Component]
   861   C1424729:VL [Gene or Genome]
   861   C1858854:VL [Disease or Syndrome]

Phrase: "Erdos MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Langefeld CD,"

Phrase: "Balow J Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Ally DS,"

Phrase: "Kohtamaki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chines P,"

Phrase: "Birznieks G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kaleta HS,"

Phrase: "Musick A,"

Phrase: "Te C,"

Phrase: "Tannenbaum J,"

Phrase: "Eldridge W,"

Phrase: "Shapiro S,"

Phrase: "Martin C,"

Phrase: "Witt A,"

Phrase: "So"

Phrase: "A,"

Phrase: "Chang J,"

Phrase: "Shurtleff B,"

Phrase: "Porter R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Boehnke M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."

Phrase: ":"
Processing 00000000.tx.166: Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. 

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "evidence for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008663:Chromosome 20 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "in 716 Finnish affected sib pairs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037047:Sib [Family Group]
   804   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.167: Proc Natl Acad Sci U S A96 :2198 2203,1999[Abstract/Free FullText] Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, Meyer J, Lewitzky S, Rennich JS, Parker A, DuPrat L, Maruti S, Chayen S, Glaser B: A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. 

Phrase: "Proc Natl Acad Sci U S A96"

Phrase: ":"

Phrase: "2198 2203,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Permutt MA,"

Phrase: "Wasson JC,"

Phrase: "Suarez BK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:BK [Gene or Genome]

Phrase: "Lin J,"

Phrase: "Thomas J,"

Phrase: "Meyer J,"

Phrase: "Lewitzky S,"

Phrase: "Rennich JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Parker A,"

Phrase: "DuPrat L,"

Phrase: "Maruti S,"

Phrase: "Chayen S,"

Phrase: "Glaser B"

Phrase: ":"

Phrase: "A genome scan for type 2 diabetes susceptibility loci"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1517519:Genome Scan [Molecular Biology Research Technique]
   742   C0017428:Genome [Gene or Genome]
   742   C0034606:Scan [Diagnostic Procedure]
   742   C0441633:Scan [Diagnostic Procedure]
   742   C2338314:Genome [Conceptual Entity]
   742   C2826292:SCAN [Finding]

Phrase: "in a genetically isolated population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.168: Diabetes50 :681 685,2001[Abstract/Free FullText] Luo TH, Zhao Y, Li G, Yuan WT, Zhao JJ, Chen JL, Huang W, Luo M: A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "681 685,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Luo TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Zhao Y,"

Phrase: "Li G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Yuan WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "Zhao JJ,"

Phrase: "Chen JL,"

Phrase: "Huang W,"

Phrase: "Luo M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "A genome-wide search for type II diabetes susceptibility genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1552603:search [Intellectual Product]
   739   C1706202:Search [Activity]

Phrase: "in Chinese Hans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551910:Han [Language]
Processing 00000000.tx.169: Diabetologia44 :501 506,2001[Medline] Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, Lecoeur C, Vatin V, Durand E, Hara K, Okada T, Tobe K, Boutin P, Kadowaki T, Froguel P: Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. 

Phrase: "Diabetologia44"

Phrase: ":"

Phrase: "501 506,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mori Y,"

Phrase: "Otabe S,"

Phrase: "Dina C,"

Phrase: "Yasuda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Populaire C,"

Phrase: "Lecoeur C,"

Phrase: "Vatin V,"

Phrase: "Durand E,"

Phrase: "Hara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Okada T,"

Phrase: "Tobe K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Boutin P,"

Phrase: "Kadowaki T,"

Phrase: "Froguel P"

Phrase: ":"

Phrase: "Genome-wide search for type 2 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1552603:search [Intellectual Product]
   748   C1706202:Search [Activity]

Phrase: "in Japanese affected sib-pairs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037047:Sib [Family Group]
   812   C1709450:Pair [Qualitative Concept]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "susceptibility genes on 3q,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0919453:Susceptibility Gene [Gene or Genome]
   770   C0017337:Genes [Gene or Genome]

Phrase: "15q,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520622:15q [Nucleotide Sequence]

Phrase: "and"

Phrase: "20q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521048:20q [Nucleotide Sequence]

Phrase: "and"

Phrase: "identifies"

Phrase: "two new candidate Loci on 7p"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "11p."
Processing 00000000.tx.170: Diabetes51 :1247 1255,2002[Abstract/Free FullText] Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "1247 1255,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Furuta H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Oda N,"

Phrase: "Kaisaki PJ,"

Phrase: "Menzel S,"

Phrase: "Cox NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Fajans SS,"

Phrase: "Signorini S,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bell GI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: ":"

Phrase: "Mutations in the hepatocyte nuclear factor-4alpha gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in maturity-onset diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332162:Onset [Qualitative Concept]
   827   C0449989:Maturity [Qualitative Concept]
   827   C0700597:Maturity [Temporal Concept]
   755 E C0205286:Mature [Temporal Concept]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.171: Nature384 :458 460,1996[Medline] Sladek FM, Zhong WM, Lai E, Darnell JE Jr.: 

Phrase: "Nature384"

Phrase: ":"

Phrase: "458 460,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sladek FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Zhong WM,"

Phrase: "Lai E,"

Phrase: "Darnell JE Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: ":"
Processing 00000000.tx.172: Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. 

Phrase: "Liver-enriched transcription factor HNF-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   867   C1420639:TRANSCRIPTION FACTOR 4 [Gene or Genome]

Phrase: "is"

Phrase: "a novel member of the steroid hormone receptor superfamily."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.173: Genes Dev4 :2353 2365,1990[Abstract] Stoffel M, Duncan SA: The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. 

Phrase: "Genes Dev4"

Phrase: ":"

Phrase: "2353 2365,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Duncan SA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: ":"

Phrase: "The maturity-onset diabetes of the young"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   905   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   905   C2984262:Maturity onset diabetes of the young [Functional Concept]
   814   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0449989:Maturity [Qualitative Concept]
   748   C0700597:Maturity [Temporal Concept]

Phrase: "(MODY1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1852093:MODY1 [Disease or Syndrome]

Phrase: ")"

Phrase: "transcription factor HNF4alpha"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "regulates"

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "required for glucose transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178666:glucose transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1317949:Transport [Manufactured Object]
   770   C1514873:Required [Functional Concept]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.174: Proc Natl Acad Sci U S A94 :13209 13214,1997[Abstract/Free FullText] Thomas H, Jaschkowitz K, Bulman M, Frayling TM, Mitchell SM, Roosen S, Lingott-Frieg A, Tack CJ, Ellard S, Ryffel GU, Hattersley AT: A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young. 

Phrase: "Proc Natl Acad Sci U S A94"

Phrase: ":"

Phrase: "13209 13214,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thomas H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Jaschkowitz K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bulman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Mitchell SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Roosen S,"

Phrase: "Lingott-Frieg A,"

Phrase: "Tack CJ,"

Phrase: "Ellard S,"

Phrase: "Ryffel GU,"

Phrase: "Hattersley AT"

Phrase: ":"

Phrase: "A distant upstream promoter of the HNF-4alpha gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0314621:Promoter gene [Gene or Genome]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0522505:Upstream [Spatial Concept]

Phrase: "connects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986575:Connect [Activity]

Phrase: "the transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "involved in maturity-onset diabetes of the young."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   909   C0342276:Maturity-onset diabetes of the young [Disease or Syndrome]
   909   C2984262:Maturity onset diabetes of the young [Functional Concept]
   800   C0011860:Maturity-Onset Diabetes [Disease or Syndrome]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332239:Young [Temporal Concept]
   744   C0449989:Maturity [Qualitative Concept]
   744   C0700597:Maturity [Temporal Concept]
   744   C1314939:Involved [Functional Concept]
Processing 00000000.tx.175: Hum Mol Genet10 :2089 2097,2001[Abstract/Free FullText] Boj SF, Parrizas M, Maestro MA, Ferrer J: A transcription factor regulatory circuit in differentiated pancreatic cells. 

Phrase: "Hum Mol Genet10"

Phrase: ":"

Phrase: "2089 2097,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Boj SF,"

Phrase: "Parrizas M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Maestro MA,"

Phrase: "Ferrer J"

Phrase: ":"

Phrase: "A transcription factor regulatory circuit in differentiated pancreatic cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   764   C0678662:regulatory circuit [Physiologic Function]
Processing 00000000.tx.176: Proc Natl Acad Sci U S A98 :14481 14486,2001[Abstract/Free FullText] Eeckhoute J, Moerman E, Bouckenooghe T, Lukoviak B, Pattou F, Formstecher P, Kerr-Conte J, Vandewalle B, Laine B: Hepatocyte nuclear factor 4 alpha isoforms originated from the P1 promoter are expressed in human pancreatic beta-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms. 

Phrase: "Proc Natl Acad Sci U S A98"

Phrase: ":"

Phrase: "14481 14486,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eeckhoute J,"

Phrase: "Moerman E,"

Phrase: "Bouckenooghe T,"

Phrase: "Lukoviak B,"

Phrase: "Pattou F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Formstecher P,"

Phrase: "Kerr-Conte J,"

Phrase: "Vandewalle B,"

Phrase: "Laine B"

Phrase: ":"

Phrase: "Hepatocyte nuclear factor 4 alpha isoforms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   780   C1415629:HEPATOCYTE NUCLEAR FACTOR 4-ALPHA [Gene or Genome]
           HEPATOCYTE NUCLEAR FACTOR 4
   780   C1565829:Hepatocyte Nuclear Factor 4-alpha [Amino Acid, Peptide, or Protein,Receptor]
   734   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "originated from the P1 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "expressed in human pancreatic beta-cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   783   C0427861:Human cells [Laboratory or Test Result]
   753   C0007634:Cells [Cell]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C2004068:Beta [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "stronger transcriptional potentials than P2 promoter-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:potentials [Qualitative Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.177: Endocrinology144 :1686 1694,2003[Abstract/Free FullText] Price JA, Fossey SC, Sale MM, Brewer CS, Freedman BI, Wuerth JP, Bowden DW: Analysis of the HNF4 alpha gene in Caucasian type II diabetic nephropathic patients. 

Phrase: "Endocrinology144"

Phrase: ":"

Phrase: "1686 1694,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Price JA,"

Phrase: "Fossey SC,"

Phrase: "Sale MM,"

Phrase: "Brewer CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Freedman BI,"

Phrase: "Wuerth JP,"

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Analysis of the HNF4 alpha gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in Caucasian type II diabetic nephropathic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.178: Diabetologia43 :364 372,2000[Medline] Bagwell AM, Bailly A, Mychaleckyj JC, Freedman BI, Bowden DW: Comparative genomic analysis of the HNF-4alpha transcription factor gene. 

Phrase: "Diabetologia43"

Phrase: ":"

Phrase: "364 372,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bagwell"

Phrase: "AM"

Phrase: ","

Phrase: "Bailly A,"

Phrase: "Mychaleckyj JC,"

Phrase: "Freedman BI,"

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Comparative genomic analysis of the HNF-4alpha transcription factor gene."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C0796358:comparative genomic analysis [Molecular Biology Research Technique]
   757   C0085801:Analysis, Factor [Quantitative Concept]
   757   C0683941:comparative analysis [Research Activity]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
Processing 00000000.tx.179: Mol Genet Metab81 :112 121,2004[Medline] Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD, Jackson AU, Deloukas P, Hunt S, Stavrides G, Chines PS, Erdos MR, Narisu N, Conneely KN, Li C, Fingerlin TE, Dhanjal SK, Valle TT, Bergman RN, Tuomilehto J, Watanabe RM, Boehnke M, Collins FS: Genetic variation near the hepatocyte nuclear factor-4 gene predicts susceptibility to type 2 diabetes. 

Phrase: "Mol Genet Metab81"

Phrase: ":"

Phrase: "112 121,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Silander K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mohlke KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Scott LJ,"

Phrase: "Peck EC,"

Phrase: "Hollstein P,"

Phrase: "Skol AD,"

Phrase: "Jackson AU,"

Phrase: "Deloukas P,"

Phrase: "Hunt S,"

Phrase: "Stavrides G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Chines PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Erdos MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Narisu N,"

Phrase: "Conneely KN,"

Phrase: "Li C,"

Phrase: "Fingerlin TE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C1705540:TE [Conceptual Entity]

Phrase: "Dhanjal SK,"

Phrase: "Valle TT,"

Phrase: "Bergman RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Tuomilehto J,"

Phrase: "Watanabe RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Boehnke M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Collins FS"

Phrase: ":"

Phrase: "Genetic variation near the hepatocyte nuclear factor-4 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0042333:Genetic Variation [Natural Phenomenon or Process]
   742   C0205419:Variation [Qualitative Concept]

Phrase: "predicts"

Phrase: "susceptibility to type 2 diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.180: Diabetes53 :1141 1149,2004[Abstract/Free FullText] Love-Gregory LD, Wasson J, Ma J, Jin CH, Glaser B, Suarez BK, Permutt MA: A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "1141 1149,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Love-Gregory LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0023746:Linkage Disequilibrium [Quantitative Concept]
   812   C0023745:linkage [Molecular Function]
   812   C0281825:Disequilibrium [Finding]
   812   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "Wasson J,"

Phrase: "Ma J,"

Phrase: "Jin CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Glaser B,"

Phrase: "Suarez BK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006100:BK [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1537501:BK [Gene or Genome]

Phrase: "Permutt MA"

Phrase: ":"

Phrase: "A common polymorphism in the upstream promoter region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "of the hepatocyte nuclear factor-4 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0017337:Gene [Gene or Genome]
   771   C0084821:Hepatocyte Nuclear Factor 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1415629:HEPATOCYTE NUCLEAR FACTOR 4 [Gene or Genome]
   717   C0872184:hepatocyte nuclear factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on chromosome 20q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521048:20q [Nucleotide Sequence]

Phrase: "is"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the evidence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332120:Evidence [Functional Concept]
   770   C1880177:Contribute [Activity]

Phrase: "for linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023745:linkage [Molecular Function]

Phrase: "in an Ashkenazi Jewish population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.181: Diabetes53 :1134 1140,2004[Abstract/Free FullText] Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI: Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "1134 1140,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bowden DW,"

Phrase: "Spray BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Rich SS,"

Phrase: "Freedman BI"

Phrase: ":"

Phrase: "Linkage analysis between loci"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0796345:linkage analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0023745:linkage [Molecular Function]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in the renin-angiotensin axis"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0004457:Axis [Body Part, Organ, or Organ Component]
   827   C0035094:Renin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0999597:Axis [Mammal]
   827   C1419338:RENIN [Gene or Genome]
   827   C1522496:Axis [Spatial Concept]
   771 E C0022877:Lab [Manufactured Object,Organization]
   771 E C0587081:Labs [Finding]

Phrase: "and"

Phrase: "end-stage renal disease in African Americans."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
   853   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   804   C0679247:disease end stage [Disease or Syndrome]
           Terminal Disease
   778   C0022658:Renal disease [Disease or Syndrome]
   778   C0205088:End-stage [Temporal Concept]
   774   C0699749:disease stage [Diagnostic Procedure]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0022646:Renal [Body Part, Organ, or Organ Component]
   748   C0205390:Stage [Temporal Concept]
   748   C0444930:End [Spatial Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C2746065:End [Temporal Concept]
Processing 00000000.tx.182: J Am Soc Nephrol7 :2559 2564,1996[Abstract] Freedman BI, Yu H, Spray BJ, Rich SS, Rothschild CB, Bowden DW: Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. 

Phrase: "J"

Phrase: "Am"

Phrase: "Soc Nephrol7"

Phrase: ":"

Phrase: "2559 2564,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Freedman BI,"

Phrase: "Yu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Spray BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Rich SS,"

Phrase: "Rothschild CB,"

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Genetic linkage analysis of growth factor loci"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0796345:genetic linkage analysis [Laboratory Procedure]
           linkage analysis
   774   C0085801:Analysis, Factor [Quantitative Concept]
   774   C0679560:genetic analysis [Laboratory Procedure]
   774   C0796344:Genetic Analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "end-stage renal disease in African Americans."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
   853   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   804   C0679247:disease end stage [Disease or Syndrome]
           Terminal Disease
   778   C0022658:Renal disease [Disease or Syndrome]
   778   C0205088:End-stage [Temporal Concept]
   774   C0699749:disease stage [Diagnostic Procedure]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0022646:Renal [Body Part, Organ, or Organ Component]
   748   C0205390:Stage [Temporal Concept]
   748   C0444930:End [Spatial Concept]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C2746065:End [Temporal Concept]
Processing 00000000.tx.183: Kidney Int51 :819 825,1997[Medline] Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI: Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. 

Phrase: "Kidney Int51"

Phrase: ":"

Phrase: "819 825,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bowden DW,"

Phrase: "Spray BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Rich SS,"

Phrase: "Freedman BI"

Phrase: ":"

Phrase: "Identification of human plasma kallikrein gene polymorphisms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0242954:Human Identification [Diagnostic Procedure]
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "evaluation of their role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "in end-stage renal disease."
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
  1000   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
  1000   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
   923   C0679247:end stage disease [Disease or Syndrome]
           Terminal Disease
   861   C0022658:Renal disease [Disease or Syndrome]
   861   C0205088:End-stage [Temporal Concept]
       E   Terminal
   812   C0012634:Disease [Disease or Syndrome]
   812   C0022646:Renal [Body Part, Organ, or Organ Component]
   812   C0205390:Stage [Temporal Concept]
   812   C0444930:End [Spatial Concept]
   812   C1300072:Stage [Clinical Attribute]
   812   C1306673:Stage [Qualitative Concept]
   812   C2746065:End [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.184: Hypertension31 :906 911,1998[Abstract/Free FullText] Yu H, Anderson PJ, Freedman BI, Rich SS, Bowden DW: Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. 

Phrase: "Hypertension31"

Phrase: ":"

Phrase: "906 911,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Anderson PJ,"

Phrase: "Freedman BI,"

Phrase: "Rich SS,"

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Genomic structure of the human plasma prekallikrein gene,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C1517495:Gene Structure [Gene or Genome]
   766   C0314607:Human structural gene [Gene or Genome]
   744   C0678594:Structure [Spatial Concept]
   731 E C0017366:Structural gene [Gene or Genome]

Phrase: "identification of allelic variants,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "analysis in end-stage renal disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   716   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
   716   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
Processing 00000000.tx.185: Genomics69 :225 234,2000[Medline] Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW: Genetic analysis of nitric oxide and endothelin in end-stage renal disease. 

Phrase: "Genomics69"

Phrase: ":"

Phrase: "225 234,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Freedman BI,"

Phrase: "Yu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Anderson PJ,"

Phrase: "Roh BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Rich SS,"

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Genetic analysis of nitric oxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0679560:genetic analysis [Laboratory Procedure]
   806   C0796344:Genetic Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "endothelin in end-stage renal disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
   716   C2316810:End-stage renal disease [Disease or Syndrome,Finding]
Processing 00000000.tx.186: Nephrol Dial Transplant15 :1794 1800,2000[Abstract/Free FullText] Freedman BI, Rich SS, Yu H, Roh BH, Bowden DW: Linkage heterogeneity of end-stage renal disease on human chromosome 10. 

Phrase: "Nephrol Dial Transplant15"

Phrase: ":"

Phrase: "1794 1800,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Freedman BI,"

Phrase: "Rich SS,"

Phrase: "Yu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Roh BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Linkage heterogeneity of end-stage renal disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "on human chromosome 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0008643:Human Chromosome [Cell Component]
   901   C0008652:Chromosome 10 [Cell Component]
   827   C0008633:Chromosome [Cell Component]
   827   C0086418:Human [Human]
Processing 00000000.tx.187: Kidney Int62 :770 774,2002[Medline] Bensen JT, Langefeld CD, Hawkins GA, Green LE, Mychaleckyj JC, Brewer CS, Kiger DS, Binford SM, Colicigno CJ, Allred DC, Freedman BI, Bowden DW: Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster. 

Phrase: "Kidney Int62"

Phrase: ":"

Phrase: "770 774,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bensen JT,"

Phrase: "Langefeld CD,"

Phrase: "Hawkins GA,"

Phrase: "Green LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Mychaleckyj JC,"

Phrase: "Brewer CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Kiger DS,"

Phrase: "Binford SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Colicigno CJ,"

Phrase: "Allred DC,"

Phrase: "Freedman BI,"

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Nucleotide variation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "haplotype structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "association with end-stage renal disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1511978:Disease Association [Temporal Concept]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]
   716   C0022661:Renal Disease, End-Stage [Disease or Syndrome]
   716   C2316810:End-stage renal disease [Disease or Syndrome,Finding]

Phrase: "of the human interleukin-1 gene cluster."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0017258:Gene cluster [Gene or Genome]
   804   C1555715:Cluster [Idea or Concept]
   804   C1704332:Cluster [Quantitative Concept]
   717   C1708431:Interleukin 1 Gene [Gene or Genome]
   708   C0314604:Human gene [Gene or Genome]
Processing 00000000.tx.188: Genomics82 :194 217,2003[Medline] Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. 

Phrase: "Genomics82"

Phrase: ":"

Phrase: "194 217,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schaid DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Rowland CM,"

Phrase: "Tines DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Jacobson RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Poland GA"

Phrase: ":"

Phrase: "Score tests for association"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   816   C0237855:score test [Qualitative Concept]
   816   C0237856:score test [Educational Activity]
   770   C0022885:Tests [Laboratory Procedure]
   770   C0392366:Tests [Intellectual Product]
   737 E C0039593:Test [Functional Concept]

Phrase: "between traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599883:traits [Organism Attribute]
  1000   C1427926:TRAITS [Gene or Genome]

Phrase: "and"

Phrase: "haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018591:Haplotypes [Organism Attribute]

Phrase: "when"

Phrase: "linkage phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "is"

Phrase: "ambiguous."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1549102:Ambiguous [Organism Attribute]
  1000   C3539086:Ambiguous [Intellectual Product]
   928 E C2346729:Ambiguity [Qualitative Concept]
Processing 00000000.tx.189: Am J Hum Genet70 :425 434,2002[Medline] Green LE, Lange EM, Langefeld CD: Power comparison for phase-known versus phase-unknown haplotype analyses for case-control designs. 

Phrase: "Am"

Phrase: "J Hum Genet70"

Phrase: ":"

Phrase: "425 434,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Green LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Lange EM,"

Phrase: "Langefeld CD"

Phrase: ":"

Phrase: "Power comparison for phase-known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "versus"

Phrase: "phase-unknown haplotype analyses for case-control designs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C2986798:Phase Analysis [Occupational Activity]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]
Processing 00000000.tx.190: Am J Hum Genet69 :1948a ,2001 Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, ORahilly S, Wareham NJ: Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. 

Phrase: "Am"

Phrase: "J Hum Genet69"

Phrase: ":"

Phrase: "1948a ,"

Phrase: "2001 Barroso I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Luan J,"

Phrase: "Middelberg RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Harding AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Franks PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Jakes RW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035978:RW [Geographic Area]
   861   C2700310:RW [Fish]

Phrase: "Clayton D,"

Phrase: "Schafer AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "ORahilly S,"

Phrase: "Wareham NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: ":"

Phrase: "Candidate gene association study in type 2 diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2717881:Candidate Gene Association Study [Molecular Biology Research Technique]
   767   C0035171:Study Type [Research Activity]
   767   C2985227:Study Type [Research Activity]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: "indicates"

Phrase: "a role for genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "involved in beta-cell function"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0007613:Cell Function [Cell Function]
   806   C0030281:Beta cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0031843:function [Physiologic Function]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705273:Function [Intellectual Product]
   760   C1948049:Cell [Spatial Concept]
   760   C2004068:Beta [Qualitative Concept]

Phrase: "as well as"

Phrase: "insulin action."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.191: PLoS Biol1 :E20 ,2003[Medline] Zhu Q, Yamagata K, Miura A, Shihara N, Horikawa Y, Takeda J, Miyagawa J, Matsuzawa Y: T130I mutation in HNF-4alpha gene is a loss-of-function mutation in hepatocytes and is associated with late-onset type 2 diabetes mellitus in Japanese subjects. 

Phrase: "PLoS Biol1"

Phrase: ":"

Phrase: "E20 ,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhu Q,"

Phrase: "Yamagata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miura A,"

Phrase: "Shihara N,"

Phrase: "Horikawa Y,"

Phrase: "Takeda J,"

Phrase: "Miyagawa J,"

Phrase: "Matsuzawa Y"

Phrase: ":"

Phrase: "T130I mutation in HNF-4alpha gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "a loss-of-function mutation in hepatocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "is"

Phrase: "associated with late-onset type 2 diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   833   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
           late onset diabetes
   833   C2984301:Type II diabetes mellitus [Functional Concept]
   770   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0205087:Late [Temporal Concept]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Japanese subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.192: Diabetologia46 :567 573,2003[Medline] Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW: Association of protein-tyrosine phosphatase1B gene polymorphisms with type 2 diabetes. 

Phrase: "Diabetologia46"

Phrase: ":"

Phrase: "567 573,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bento JL,"

Phrase: "Palmer ND,"

Phrase: "Mychaleckyj JC,"

Phrase: "Lange LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Langefeld CD,"

Phrase: "Rich SS,"

Phrase: "Freedman BI,"

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Association of protein-tyrosine phosphatase1B gene polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.193: Diabetes53 :3007 3012,2004[Abstract/Free FullText] Palmer ND, Bento JL, Mychaleckyj JC, Langefeld CD, Campbell JK, Norris JM, Haffner SM, Bergman RN, Bowden DW: Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the IRAS Family Study. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "3007 3012,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Palmer ND,"

Phrase: "Bento JL,"

Phrase: "Mychaleckyj JC,"

Phrase: "Langefeld CD,"

Phrase: "Campbell JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Norris JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Haffner SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Bergman RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Bowden DW"

Phrase: ":"

Phrase: "Association of protein tyrosine phosphatase 1B gene polymorphisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with measures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079809:Measures [Quantitative Concept]
  1000   C1879489:Measures [Functional Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "of glucose homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "in Hispanic Americans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019576:Hispanic Americans [Population Group]
           Hispanic
   861   C0086409:Hispanic [Population Group]
   861   C0596070:americans [Population Group]

Phrase: ":"

Phrase: "the IRAS Family Study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0199236:Family study, NOS [Diagnostic Procedure]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]
Processing 00000000.tx.194: Diabetes53 :3013 3019,2004[Abstract/Free FullText] Abecasis GR, Cookson WO: GOLD: graphical overview of linkage disequilibrium. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "3013 3019,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Abecasis GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Cookson WO"

Phrase: ":"

Phrase: "GOLD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0814812:overview [Intellectual Product]

Phrase: ":"

Phrase: "graphical overview of linkage disequilibrium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814812:overview [Intellectual Product]
Processing 00000000.tx.195: Bioinformatics16 :182 183,2000[Abstract] This Article Abstract Full Text (PDF) Appendix Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Bagwell, A. 

Phrase: "Bioinformatics16"

Phrase: ":"

Phrase: "182 183,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF) Appendix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003617:Appendix [Body Part, Organ, or Organ Component]
   861   C1269000:Appendix [Body Part, Organ, or Organ Component]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Request Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Bagwell,"

Phrase: "A."
Processing 00000000.tx.196: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.197: Articles by Bowden, D. 

Phrase: "Articles by Bowden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.198: W. 

Phrase: "W."
Processing 00000000.tx.199: Articles citing this Article PubMed PubMed Citation Articles by Bagwell, A. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Bagwell,"

Phrase: "A."
Processing 00000000.tx.200: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.201: Articles by Bowden, D. 

Phrase: "Articles by Bowden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.202: W. 

Phrase: "W."
Processing 00000000.tx.203: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum DOC News

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Diabetes Diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0039224:Table [Manufactured Object]
   738   C1706073:Table [Medical Device]
   738   C1706074:Table [Intellectual Product]

Phrase: "Care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "Clinical Diabetes Diabetes Spectrum DOC News"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0282425:News [Intellectual Product]

